Item 9A. Controls and Procedures
Item 9A. CONTROLS AND PROCEDURES
Evaluation of Disclosure Controls and Procedures
Disclosure controls are procedures
that are designed with the objective of ensuring that information required to be disclosed in our reports filed under the Exchange Act,
such as this Annual Report, is recorded, processed, summarized, and reported within the time period specified in the SEC’s rules
and forms. Disclosure controls are also designed with the objective of ensuring that such information is accumulated and communicated
to our management, including the chief executive officer and chief financial officer, as appropriate to allow timely decisions regarding
required disclosure. Our management evaluated, with the participation of our chief executive officer and chief financial officer (our
“Certifying Officers”), the effectiveness of our disclosure controls and procedures as of December 31, 2025, pursuant to Rule 13a-15(b)
under the Exchange Act. Based upon that evaluation, our Certifying Officers concluded that as of December 31, 2025, our disclosure controls
and procedures were effective.
We do not expect that our
disclosure controls and procedures will prevent all errors and all instances of fraud. Disclosure controls and procedures, no matter how
well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the disclosure controls and procedures
are met. Further, the design of disclosure controls and procedures must reflect the fact that there are resource constraints, and the
benefits must be considered relative to their costs. Because of the inherent limitations in all disclosure controls and procedures, no
evaluation of disclosure controls and procedures can provide absolute assurance that we have detected all our control deficiencies and
instances of fraud, if any. The design of disclosure controls and procedures also is based partly on certain assumptions about the likelihood
of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future
conditions.
Management’s Report on Internal Controls
Over Financial Reporting
This Annual Report does not
include a report of management’s assessment regarding internal control over financial reporting or an attestation report of the
Company’s registered public accounting firm due to a transition period established by rules of the SEC for newly public companies.
Changes in Internal Control Over Financial
Reporting
There were no changes in our
internal control over financial reporting (as such term is defined in Rules 13a-15(f) and 15d-15(f) of the Exchange Act) during the most
recent fiscal quarter that have materially affected, or are reasonably likely to materially affect, our internal control over financial
reporting.
Item 9B. OTHER INFORMATION
None.
Item 9C. DISCLOSURE REGARDING FOREIGN JURISDICTIONS
THAT PREVENT INSPECTIONS
None.
70
PART III
Item 10. DIRECTORS, EXECUTIVE OFFICERS,
AND CORPORATE GOVERNANCE.
Directors and Executive Officers
Our directors and executive
officers are as follows:
Name
Age
Title
Betsy Cohen
84
Director and Chairman of the Board
Bracebridge H. Young, Jr.
67
President, Chief Executive Officer and Director
R. Maxwell Smeal
36
Chief Financial Officer
Jonathan Kirkwood
43
Director and Vice Chairman of the Board
Andrew Hohns
45
Director
Grant Gilliam
42
Director
Hersh Kozlov
76
Director
Betsy Cohen has served
as Chairman of our board of directors since April 2023. She served as Chairman of the board of directors of FTAC Emerald from April 2021
until its February 2025 business combination with Fold Holdings, Inc. Ms. Cohen served as Chairman, President and Chief Executive
Officer of Cohen Circle I from October 2021 until the consummation of its business combination with Kyivstar Group Ltd., in August 2025,
and has served as a director of Kyivstar Group Ltd. since then. She is currently President and Chief Executive Officer of Cohen Circle
II, a managing member of the general partner of Cohen Circle FinTech Ventures, L.P., a fintech focused venture capital fund, since January
2023, and a managing member of the general partner of Radiate Capital Fund, L.P., an impact investment fund with a focus on the financial
services and health sectors, since June 2024. Ms. Cohen served as Chairman of FinTech VI’s board of directors from November 2020
until December 2022, FinTech V’s board of directors from June 2019 until December 2022, FinTech IV’s
board of directors from May 2019 until June 2021, FTAC Olympus’ board of directors from June 2020 until June 2021,
FinTech III’s board of directors from March 2017 until October 2020, and FinTech II’s board of directors
from August 2016 until July 2018. She served as a director of FinTech I and its successor, Card Connect Corp., a provider
of payment processing solutions to merchants, from November 2013 until May 2017, and previously served as Chairman of the board
of directors of FinTech I from July 2014 through July 2016 and as FinTech I’s Chief Executive Officer from July 2014
through August 2014. She served as Chief Executive Officer of Bancorp and its wholly-owned subsidiary, Bancorp Bank, from September 2000
and Chairman of Bancorp Bank from November 2003, and resigned from these positions upon her retirement in December 2014. She
served as the Chairman of the Board of Trustees and as a trustee of RAIT Financial Trust, a real estate investment trust, from its founding
in August 1997, through her resignation as of December 31, 2010 and served as RAIT’s Chief Executive Officer from 1997
to 2006. Ms. Cohen served as a director of Hudson United Bancorp (a bank holding company), the successor to JeffBanks, Inc., from
December 1999 until July 2000 and as the Chairman of the Jefferson Bank Division of Hudson United Bank (Hudson United Bancorp’s
banking subsidiary) from December 1999 through March 2000. Before the merger of JeffBanks, Inc. with Hudson United Bancorp in
December 1999, Ms. Cohen was Chairman and Chief Executive Officer of JeffBanks, Inc. from its inception in 1981 and also served
as Chairman and Chief Executive Officer of each of its subsidiaries, Jefferson Bank, which she founded in 1974, and Jefferson Bank
New Jersey, which she founded in 1987. From 1985 until 1993, Ms. Cohen was a director of First Union Corp. of Virginia
(a bank holding company) and its predecessor, Dominion Bancshares, Inc. In 1969, Ms. Cohen co-founded a commercial law firm
and served as a senior partner until 1984. Ms. Cohen also served as a director of Aetna, Inc. (NYSE: AET), an insurance
company, from 1994 until May 2018 and as a director of Metromile, Inc., the successor to INSU II, from February 2021 until
July 2021. Our board has determined that Ms. Cohen’s extensive experience in the financial services industry generally,
and the financial technology industry in particular, as well as extensive experience in operating financial services companies in a public
company environment, qualifies her to serve as a member of our Board.
Bracebridge H. Young,
Jr. has served as our President and Chief Executive Officer and on our board of directors since October 2025. He serves as
Vice Chairman of Bracebridge Capital, a Boston based hedge fund. In addition, Mr. Young serves as a member of the board of advisors
of Newmarket Investment Advisors and Upwell Water, a technology-enabled water asset management company. Mr. Young previously
served as FTAC Emerald’s President and Chief Executive Officer from June 2021 to February 2025. Since, February 2025, Mr. Young
has served as a director of Fold Holdings, Inc., a bitcoin financial services company dedicated to expanding access to bitcoin through
a comprehensive suite of consumer financial products. Mr. Young served as Chief Executive Officer of Eclat Impact in 2016. From 2000
through 2015, Mr. Young served as Chief Executive Officer and Partner of Mariner Investment Group. He joined Mariner directly from
Goldman Sachs, where he began on the Commercial Paper trading desk in 1980 and subsequently served as Head Trader of Institutional Liquid
Assets, Co-Head of the Money Market Sales and Trading Department in New York, Partner in charge of Fixed-Income in Tokyo,
Head of Fixed-Income and foreign exchange sales in London, and, finally, Partner and Head of European Debt Capital Markets in New York.
Mr. Young serves on the board of directors of Social Finance USA, a Boston-based nonprofit organization dedicated to mobilizing
investment capital to drive social change, serves on the boards of directors for Social Progress Imperative, a non-profit best known
for measuring a government’s social and environmental performance, Cultivo, a platform designed to finance the regeneration
of nature, and TerViva, an agricultural innovation company partnering with farmers to grow and harvest Pongamia. Mr. Young received
a B.A from Bowdoin College in 1977 and an M.B.A. from New York University’s Stern School of Business in 1983. We believe that
Mr. Young’s experience in corporate leadership and private equity makes him qualified to serve as a member of our Board.
71
R. Maxwell Smeal has
served as our Chief Financial Officer since September 2025. Since August 2025, Mr. Smeal has served as Chief Financial
Officer of Art Technology Acquisition Corp. (Nasdaq: ARTC), and, since March 2025, as Chief Financial Officer of Cohen Circle II. From
October 2024 to August 2025, Mr. Smeal served as the Chief Financial Officer of Cohen Circle I. From July 2021
to December 2023 he served as the Head of Finance and since January 2024 he has served as Chief Financial Officer of Cohen Circle, LLC
(formerly FinTech Masala, LLC), the parent company of the sponsors of FinTech II, FinTech III, FinTech IV, FinTech V,
FinTech VI, FTAC Olympus, FTAC Athena, FTAC Zeus, FTAC Parnassus and FTAC Emerald. Previously, he served as a Director in KPMG LLP’s
Deal Advisory practice from October 2019 through July 2021. Prior to being named a Director at KPMG, he served in various roles
within KPMG LLP in their Deal Advisory and Audit practices from October 2012 to October 2019. Mr. Smeal has been a Certified Public
Accountant since June 2014 and graduated from the Pennsylvania State University with a B.S. in accounting.
Jonathan Kirkwood has
served as Vice Chairman of our board of directors since October 2025. Dr. Kirkwood co-founded Ten31 LLC, a leading bitcoin investment
platform in 2020 and has served as its Managing Partner since its inception. As Managing Partner of Ten31 LLC, Dr. Kirkwood leverages
his extensive experience in fintech and bitcoin investment management, strategic advisory, and business development to oversee the deployment
of over $130 million across 35 companies within the bitcoin ecosystem. Dr. Kirkwood’s expertise in capital raising, regulatory
compliance and portfolio management have been critical in guiding high-risk, high-uncertainty ventures to successful outcomes. His
leadership spans various sectors, including bitcoin mining, exchanges, payments, security software and hardware, and AI-driven tools.
Dr. Kirkwood sits on the board of directors of Fold Holdings, Inc., a bitcoin financial services company dedicated to expanding access
to bitcoin through a comprehensive suite of consumer financial products and Start9 Labs Inc., a user-friendly platform provider for
personal servers, and Battery Finance, Inc., a subsidiary of Newmarket Capital focused on institutional investment strategies related
to bitcoin. Dr. Kirkwood holds a B.S. in Biology from the University of Evansville, an M.D. from Ross University School of Medicine
and an M.B.A. from Ball State University. We believe Dr. Kirkwood’s strategic insight, leadership experience and industry expertise
make him well qualified to serve as a member of our Board.
Andrew Hohns has served
as a member of our board of directors since October 2025. Dr. Hohns is Chief Executive Officer of Newmarket Capital, a registered
investment advisor he founded in 2020. Newmarket Capital manages capital on behalf of institutional investors worldwide, specializing
in structured credit opportunities. In 2022, Newmarket Capital established Battery Finance, Inc., a subsidiary focused on institutional
investment strategies related to bitcoin. Since, February 2025, Dr. Hohns has served as a director of Fold Holdings, Inc., a bitcoin financial
services company dedicated to expanding access to bitcoin through a comprehensive suite of consumer financial products. Dr. Hohns is a
regular speaker at industry conferences, with expertise in infrastructure, securitization, socially responsible investment, impact investment,
development finance, and bitcoin. Prior to establishing Newmarket Capital, Dr. Hohns was a Managing Director at Mariner Investment
Group from 2012 through 2020, and a Managing Director at Cohen & Company from 2005 through 2012. He was a Director of INSU Acquisition
Corp II from September 2020 to February 2021. Since 2016, Dr. Hohns has served as a Director of UNICEF USA. Dr. Hohns
holds a B.S. in Economics from The Wharton School at the University of Pennsylvania, a Masters in Liberal Arts from the School of Arts
and Sciences at the University of Pennsylvania, and a PhD in Applied Economics and Managerial Sciences from The Wharton School at the
University of Pennsylvania. We believe that Mr. Hohns’ experience in structured finance and investment management makes him qualified
to serve as a member of our Board.
Grant Gilliam has served as
a member of our board of directors since October 2025. Mr. Gilliam co-founded Ten31 LLC, a leading investment platform focused
on bitcoin, in 2020 and has served as its Managing Partner since its inception. Mr. Gilliam brings over 15 years of institutional
investing experience to his role at Ten31 LLC, having most recently served as a Director at CVC Capital Partners plc, a large global private
equity firm with over $50 billion in assets under management. During his time at CVC, Mr. Gilliam was responsible for leading
the US efforts of CVC Strategic Opportunities, which managed approximately $10 billion across a range of industries. As part of this
role, Mr. Gilliam completed investments totaling more than $3 billion and served on several boards of multi-billion dollar
companies. Prior to joining CVC, Grant spent three years at Credit Suisse in the Leveraged Finance Origination group in New York
and London. Mr. Gilliam also has a long track record in venture investing, having invested in approximately 100 early-stage companies
over 10 years, and he currently sits on the board of Strike, one of the world’s largest bitcoin financial services platforms.
Mr. Gilliam holds a B.S. in Electrical Engineering from Duke University. We believe Mr. Gilliam’s industry expertise make him
well qualified to serve as a member of our Board.
72
Hersh Kozlov has served as a
member of our board of directors since October 2025. Mr. Kozlov has over thirty years of legal experience counseling clients in the
areas of litigation, federal and state regulatory matters, gaming law and complex financial institution management. Mr. Kozlov has
been a partner at Duane Morris LLP, an international law firm, since 2009 and serves on the governing board of the law firm. Previously,
he was a partner at the law firm Wolf, Block, Schorr and Solis-Cohen LLP from 2001 to 2009. Mr. Kozlov currently serves on the
board of directors of The Bancorp, Inc. (TBBK; NASDAQ). Mr. Kozlov previously served as an independent member of the board of directors
of vTv Therapeutics, Inc. (Nasdaq: VTVT), a biopharmaceutical company, from September 2019 through February 2023, and also has served
on the board of directors of Resource America, Inc. (REXI; NASDAQ), JeffBanks, Inc. (JEFF; NASDAQ), TRM Corporation (TRM; NASDAQ), Hudson
United Bank (HUB; NYSE), U.S. Healthcare Life Insurance Company, and Princeton Insurance Company. In addition, Mr. Kozlov was appointed
by the President of the United States to be a member of the Advisory Committee for Trade Policy & Negotiations, serving in that role
from 2002 to 2004. Mr. Kozlov holds a B.A. from Temple University and a Juris Doctor from Case Western Reserve University School
of Law. We believe Mr. Kozlov’s extensive legal and business experience with a variety of entities, including banks, insurance
companies, and other financial institutions, make him well qualified to serve as a member of our Board.
Number and Terms of Office of Officers and
Directors
Our board of directors consists
of six members divided into three classes with only one class of directors being appointed in each year, and each class (except for those
directors appointed prior to our first annual meeting of shareholders) serving a three-year term. The term of office of the first
class of directors, consisting of Andrew Hohns and Hersh Kozlov, will expire at our first annual meeting of shareholders. The term of
office of the second class of directors, consisting of Bracebridge H. Young, Jr. and Grant Gilliam, will expire at the second annual meeting
of shareholders. The term of office of the third class of directors, consisting of Betsy Z. Cohen and Jonathan Kirkwood, will expire at
the third annual meeting of shareholders. Prior to our initial business combination, as long as there are Class B ordinary shares outstanding,
holders of our founder shares will have the right to appoint all of our directors and remove members of the board of directors for any
reason, and holders of our public shares will not have the right to vote on the appointment of directors during such time. These provisions
of our amended and restated memorandum and articles of association may only be amended by a special resolution passed by a majority of
at least 90% of our ordinary shares attending and voting in a general meeting. Each of our directors will hold office for a three-year term.
Subject to any other special rights applicable to the shareholders, any vacancies on our board of directors may be filled by the affirmative
vote of a majority of the directors present and voting at the meeting of our board of directors or by a majority of the holders of our
ordinary shares (or, prior to our initial business combination, holders of our founder shares).
Our officers are appointed
by the board of directors and serve at the discretion of the board of directors, rather than for specific terms of office. Our board of
directors is authorized to appoint persons to the offices set forth in our amended and restated memorandum and articles of association
as it deems appropriate. Our amended and restated memorandum and articles of association provide that our officers may consist of a Chairman,
Chief Executive Officer, President, Chief Financial Officer, Chief Operating Officer, Vice Presidents, Secretary, Assistant Secretaries,
Treasurer and such other offices as may be determined by the board of directors.
Delinquent Section 16(a) Reports
Section 16(a) of the Exchange
Act requires our executive officers and directors, and persons who own more than ten percent of any publicly traded class of our equity
securities, to file reports of ownership and changes in ownership of equity securities of the Company with the SEC. Officers, directors,
and greater-than-ten-percent shareholders are required by the SEC’s regulations to furnish the Company with copies of all Section
16(a) forms that they file.
Based solely upon a review
of Forms 3 and Forms 4 furnished to the Company during the most recent fiscal year, and Forms 5 with respect to its most recent fiscal
year, we believe that all such forms required to be filed pursuant to Section 16(a) of the Exchange Act were timely filed by the officers,
directors, and security holders required to file the same during the fiscal year ended December 31, 2025.
73
Board Committees
Audit Committee
We have established an audit
committee of the Board of Directors. Andrew Hohns, Hersh Kozlov and Jonathan Kirkwood serve as members of our audit committee. Under Nasdaq listing
standards and applicable SEC rules, we are required to have at least three members of the audit committee, all of whom must be independent.
Andrew Hohns, Hersh Kozlov and Jonathan Kirkwood each meet the independent director standard under Nasdaq’s listing standards
and under Rule 10A-3(b)(1) of the Exchange Act, and Mr. Hohns serves as chairman of the audit committee.
The audit committee’s
duties, which are specified in our Audit Committee Charter, include, but are not limited to:
●
assisting board oversight of (1) the integrity of our financial statements, (2) our compliance with legal and regulatory requirements, (3) our independent registered public accounting firm’s qualifications and independence, and (4) the performance of our internal audit function and independent registered public accounting firm;
●
the appointment, compensation, retention, replacement, and oversight of the work of the independent auditors and any other independent registered public accounting firm engaged by us;
●
pre-approving all audit and non-audit services to be provided by the independent auditors or any other registered public accounting firm engaged by us, and establishing pre-approval policies and procedures;
●
reviewing and discussing with the independent auditors all relationships the auditors have with us in order to evaluate their continued independence;
●
setting clear hiring policies for employees or former employees of the independent auditors;
●
setting clear policies for audit partner rotation in compliance with applicable laws and regulations;
●
obtaining and reviewing a report, at least annually, from the independent auditors describing (i) the independent auditor’s internal quality-control procedures and (ii) any material issues raised by the most recent internal quality-control review, or peer review, of the audit firm, or by any inquiry or investigation by governmental or professional authorities, within, the preceding five years respecting one or more independent audits carried out by the firm and any steps taken to deal with such issues;
●
meeting to review and discuss our annual audited financial statements and quarterly financial statements with management and the independent registered public accounting firm, including reviewing our specific disclosures under “Management’s Discussion and Analysis of Financial Condition and Results of Operations”;
●
reviewing and approving any related party transaction required to be disclosed pursuant to Item 404 of Regulation S-K promulgated by the SEC prior to us entering into such transaction; and
●
reviewing with management, the independent auditors, and our legal advisors, as appropriate, any legal, regulatory or compliance matters, including any correspondence with regulators or government agencies and any employee complaints or published reports that raise material issues regarding our financial statements or accounting policies and any significant changes in accounting standards or rules promulgated by the Financial Accounting Standards Board, the SEC or other regulatory authorities.
Financial Expert on Audit Committee
The audit committee will at
all times be composed exclusively of directors who are “financially literate” as defined under NASDAQ’s listing standards.
The NASDAQ listing standards define “financially literate” as being able to read and understand fundamental financial statements,
including a company’s balance sheet, income statement and cash flow statement.
In addition, we must certify
to the NASDAQ Global Market that the committee has, and will continue to have, at least one member who has past employment experience
in finance or accounting, requisite professional certification in accounting, or other comparable experience or background that results
in the individual’s financial sophistication. We have determined that Mr. Hohns satisfies NASDAQ’s definition of financial
sophistication and also qualifies as an “audit committee financial expert,” as defined under rules and regulations of the
SEC.
74
Compensation Committee
We have established a compensation
committee of the board of directors, which consists of Hersh Kozlov, Andrew Hohns and Grant Gilliam, each of whom meets the independent
director standard under NASDAQ’s listing standards and under Rule 10A-3(b)(1) of the Exchange Act. Mr. Kozlov serves as Chairman
of our compensation committee.
The compensation committee’s
duties, which are specified in our Compensation Committee Charter, include, but are not limited to:
●
reviewing and approving on an annual basis the corporate goals and objectives relevant to our Chief Executive Officer’s compensation, evaluating our Chief Executive Officer’s performance in light of such goals and objectives and determining and approving the remuneration (if any) of our Chief Executive Officer’s based on such evaluation;
●
reviewing and approving the compensation of all of our other executive officers;
●
reviewing our executive compensation policies and plans;
●
implementing and administering our incentive compensation equity-based remuneration plans;
●
assisting management in complying with our proxy statement and annual report disclosure requirements;
●
approving all special perquisites, special cash payments and other special compensation and benefit arrangements for our executive officers and employees;
●
producing a report on executive compensation to be included in our annual proxy statement; and
●
reviewing, evaluating and recommending changes, if appropriate, to the remuneration for directors.
The charter also provides
that the compensation committee may, in its sole discretion, retain or obtain the advice of a compensation consultant, legal counsel or
other adviser and will be directly responsible for the appointment, compensation and oversight of the work of any such adviser. However,
before engaging or receiving advice from a compensation consultant, external legal counsel or any other adviser, the compensation committee
will consider the independence of each such adviser, including the factors required by Nasdaq and the SEC.
Other Board Committees
We do not have a standing
nominating committee though we intend to form a corporate governance and nominating committee as and when required to do so by law or
Nasdaq rules. In accordance with Rule 5605 of the Nasdaq rules, a majority of the independent directors may recommend a director
nominee for selection by the board of directors. The board of directors believes that the independent directors can satisfactorily carry
out the responsibility of properly selecting or approving director nominees without the formation of a standing nominating committee.
The directors who will participate in the consideration and recommendation of director nominees are Hersh Kozlov, Andrew Hohns and Grant
Gilliam. In accordance with Rule 5605 of the Nasdaq rules, all such directors are independent. As there is no standing nominating
committee, we do not have a nominating committee charter in place.
Prior to our initial business
combination, the board of directors will also consider director candidates recommended for nomination by holders of our founder shares
during such times as they are seeking proposed nominees to stand for appointment at an annual general meeting (or, if applicable, an extraordinary
general meeting). Prior to our initial business combination, holders of our public shares will not have the right to recommend director
candidates for nomination to our board.
We have not formally established
any specific, minimum qualifications that must be met or skills that are necessary for directors to possess. In general, in identifying
and evaluating nominees for director, the board of directors considers educational background, diversity of professional experience, knowledge
of our business, integrity, professional reputation, independence, wisdom, and the ability to represent the best interests of our shareholders.
75
Insider Trading Policy
We have adopted insider trading policies and procedures governing the purchase, sale, and/or other dispositions of our securities by directors, officers and employees that are reasonably designed to promote compliance with insider trading laws, rules and regulations, and any listing standards applicable to us. A copy of our Insider Trading Policy has been filed as Exhibit 19 to this Annual Report.
Code of Ethics
We have adopted a code of
ethics applicable to our directors, officers and employees in accordance with applicable federal securities laws, a copy of which is filed
as an exhibit to this Annual Report. We will make a printed copy of our code of ethics available to any shareholder who so requests. Requests
for a printed copy may be directed to us as follows: BTC Development Corp., 2929 Arch Street, Suite 1703, Philadelphia, PA 19104 Attention:
Secretary.
Item 11. EXECUTIVE COMPENSATION.
None of our executive officers
or directors have received any cash compensation for services rendered. Our independent directors each received, for their services as
a director, an indirect interest in 20,000 founder shares through membership interests in our sponsor. We are not prohibited from
paying any fees (including advisory fees), reimbursements or cash payments to any of our sponsor, officers or directors, or any of their
respective affiliates, for services rendered to us prior to or in connection with the completion of our initial business combination,
including the following payments, all of which, if made prior to the completion of our initial business combination, will be paid from
funds held outside the trust account: (i) repayment of loans made to us by our sponsor to cover offering-related and organization
expenses, (ii) repayment of loans that our sponsor, members of our management team or any of their respective affiliates may make
to finance transaction costs in connection with an intended initial business combination (provided that if we do not consummate an initial
business combination, we may use working capital held outside the trust account to repay such loaned amounts, but no proceeds from our
trust account would be used for such repayment), (iii) payments to our sponsor or its affiliate or designee of a total of $30,000
per month for office space, utilities, and shared personnel support services, (iv) payments of up to $12,500 per month to R. Maxwell
Smeal, our Chief Financial Officer, (v) at the closing of our initial business combination, at the option of our management team, a customary
advisory fee, finder’s fee and/or success fee, to a person or entity associated with certain of our officers and directors, in an
amount that constitutes a market standard advisory fee for comparable transactions and services provided; and (vi) to reimburse for
any out-of-pocket expenses related to identifying, investigation and completing an initial business combination. Our audit committee
will review on a quarterly basis all payments made by us to our sponsor, officers or directors or any of their controlled affiliates.
After the completion of our
initial business combination, directors or members of our management team who remain with us may be paid consulting, management or other
fees from the post-transaction company. All of these fees will be fully disclosed to shareholders, to the extent then known, in the tender
offer materials or proxy solicitation materials furnished to our shareholders in connection with a proposed business combination. It is
unlikely the amount of such compensation will be known at the time such materials are distributed, because the directors of the post-combination business
will be responsible for determining officer and director compensation. Any compensation to be paid to our officers will be determined
by a compensation committee constituted solely by independent directors or by a majority of the independent directors on our board of
directors.
We do not intend to take any
action to ensure that members of our management team maintain their positions with us after the consummation of our initial business combination,
although it is possible that some or all of our officers and directors may negotiate employment or consulting arrangements to remain with
us after the initial business combination. The existence or terms of any such employment or consulting arrangements to retain their positions
with us may influence our management’s motivation in identifying or selecting a target business but we do not believe that the ability
of our management to remain with us after the consummation of our initial business combination will be a determining factor in our decision
to proceed with any potential business combination. We are not party to any agreements with our officers and directors that provide for
benefits upon termination of employment.
Compensation Committee Interlocks and Insider
Participation
None of our officers currently
serves, and in the past year has not served, (i) as a member of the compensation committee or board of directors of another entity,
one of whose executive officers served on our compensation committee, or (ii) as a member of the compensation committee of another
entity, one of whose executive officers served on our board of directors.
76
Item 12. SECURITY OWNERSHIP OF CERTAIN
BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS.
The following table sets forth
information regarding the beneficial ownership of our ordinary shares as of March 20, 2026, by :
●
each person known by us to be the beneficial owner of more than 5% of our outstanding ordinary shares;
●
each of our named executive officers and directors that beneficially owns ordinary shares; and
●
all our executive officers and directors as a group.
The table below represents
beneficial ownership of our Class A ordinary shares and Class B ordinary shares and is reported in accordance with the beneficial ownership
rules of the SEC under which a person is deemed to be the beneficial owner of a security if that person has or shares voting power or
investment power with respect to such security or has the right to acquire such ownership within 60 days. The table does not reflect record
or beneficial ownership of any outstanding warrants as no warrants are exercisable within 60 days.
The beneficial ownership of
the Company’s voting ordinary shares is based on 26,060,000 Class A ordinary shares and 8,686,667 Class B ordinary shares outstanding,
except as otherwise indicated.
Unless otherwise indicated,
we believe that all persons named in the table have sole voting and investment power with respect to all shares of common stock beneficially
owned by them.
Name and Address of
Class A
Ordinary Shares
Class B
Ordinary Shares
Combined
Voting Power (2)
Beneficial Owners
Number
% of class
Number
% of class
Number
% of class
Directors and Executive Officers : (1)
Betsy Z. Cohen (2)(3)
512,500
2.0 %
8,686,667
100.0 %
9,118,333
26.3 %
Bracebridge H. Young, Jr. (2)
512,500
2.0 %
4,590,834
52.8 %
5,103,334
14.7 %
Jonathan Kirkwood (2)
512,500
2.0 %
4,590,834
52.8 %
5,103,334
14.7 %
R. Maxwell Smeal
–
–
–
–
–
–
Andrew Hohns
–
–
–
–
–
–
Grant Gilliam
–
–
–
–
–
–
Hersh Kozlov
–
–
–
–
–
–
All directors and executive officers as a group (seven individuals) (2)(3)
512,500
2.0 %
8,686,667
100.0 %
9,199,167
26.5 %
5% or Greater Beneficial Owners:
TD SECURITIES (USA) LLC (4)
1,332,581
5.1 %
-
-
1,332,581
3.8 %
Meteora Capital, LLC (5)
1,831,855
7.0 %
-
-
1,831,855
5.3 %
BTC Development Sponsor LLC (2)
512,500
2.0 %
4,590,834
52.8 %
5,103,334
14.7 %
BTC Development Advisors LLC (3)
–
–
4,095,833
47.2 %
4,095,833
11.8 %
*
Less than 1 percent.
1.
Unless otherwise noted, the business address of each of the following individuals is c/o BTC Development Corp., 2929 Arch Street, Suite 1703, Philadelphia, PA 19104.
2.
Shares are held directly by BTC Development Sponsor LLC, which is managed by Betsy Z. Cohen, Jonathan Kirkwood, and Bracebridge H. Young, Jr. Betsy Z. Cohen, Jonathan Kirkwood, and Bracebridge H. Young, Jr. are the managers of BTC Development Sponsor LLC and are deemed to each hold voting and investment power over the shares held directly by BTC Development Sponsor LLC. Our officers and directors are members of our sponsor. Each such person disclaims any beneficial ownership of the reported shares other than to the extent of any pecuniary interest they may have therein, directly or indirectly.
3.
Shares are held directly by BTC Development Advisors LLC. Betsy Z. Cohen is the manager of BTC Development Advisors LLC and is deemed to hold voting and investment power over the shares held directly by BTC Development Advisors LLC. Betsy Z. Cohen disclaims any beneficial ownership of the reported shares other than to the extent of any pecuniary interest she may have therein, directly or indirectly.
4.
Based on a Schedule 13G filed on February 13, 2026 by TD SECURITIES (USA) LLC (“TDS”), Toronto Dominion Holdings USA Inc. (“TDH”), TD Group US Holdings LLC (“TD GUS”) and Toronto Dominion Bank (“TD Bank”). TD Bank has the sole power to vote or direct the vote and the sole power to dispose or direct the disposition of 1,200,000 of the reported shares and TDS has the sole power to vote or direct the vote and the sole power to dispose or direct the disposition of 132,581 of the reported shares. TDH is the sole owner of TDS. TD GUS is the sole owner of TDH. TD Bank is the sole owner of TD GUS. TDH, TD GUS and TD Bank may be deemed to hold an indirect interest in the shares reported herein by TDS by virtue of their ownership of TDS. The business address of TDS and TDH is One Vanderbilt Avenue, New York, New York 10017. The business address of TD GUS is 251 Little Falls Drive, Wellington, Delaware 19808. The business address of TD Bank is Toronto-Dominion Centre, 66 Wellington Street West, 12th Floor, TD Tower, Toronto, Ontario, Canada M5K 1A2.
5.
Based on a Schedule 13G filed on February 13, 2026 by Meteora Capital, LLC (Meteora Capital”) and Vik Mittal. Meteora Capital serves as investment manager to certain funds and managed accounts that hold the reported shares. Vik Mittal serves as the Managing Member of Meteora Capital. The address of the principal business office for each of the Reporting Persons is 1200 N Federal Hwy, #200, Boca Raton FL 33432.
77
Item 13. CERTAIN RELATIONSHIPS AND RELATED
TRANSACTIONS, AND DIRECTOR INDEPENDENCE.
Related Party Policy
We have adopted a code of
ethics requiring us to avoid, wherever possible, all conflicts of interests, except under guidelines or resolutions approved by our board
of directors (or the appropriate committee of our board) or as disclosed in our public filings with the SEC. Under our code of ethics,
conflict of interest situations include any financial transaction, arrangement or relationship (including any indebtedness or guarantee
of indebtedness) involving the company. We have filed our code of ethics as an exhibit to this Annual Report.
In addition, our audit committee,
pursuant to a written charter, is responsible for reviewing and approving related party transactions to the extent that we enter into
such transactions. An affirmative vote of a majority of the members of the audit committee present at a meeting at which a quorum is present
is required in order to approve a related party transaction. A majority of the members of the entire audit committee constitute a quorum.
Without a meeting, the unanimous written consent of all of the members of the audit committee is required to approve a related party transaction.
We also require each of our directors and executive officers to complete a directors’ and officers’ questionnaire that elicits
information about related party transactions.
These procedures are intended
to determine whether any such related party transaction impairs the independence of a director or presents a conflict of interest on the
part of a director, employee or officer.
To further minimize conflicts
of interest, we have agreed not to consummate an initial business combination with an entity that is affiliated with any of our sponsor,
officers or directors unless we, or a committee of independent and disinterested directors, have obtained an opinion from an independent
investment banking firm which is a member of FINRA or an independent accounting firm that commonly renders valuation opinions, that our
initial business combination is fair to our company from a financial point of view.
Founder shares
Upon our incorporation, our
sponsor paid certain offering costs totaling $25,000 and subsequently received 8,686,667 founder shares in exchange. The number of founder
shares was determined based on the expectation that the founder shares would represent 25% of the aggregate of our founder shares, the
placement shares and our issued and outstanding public shares after the initial public offering.
Our initial holders, sponsor
and our management team have agreed not to transfer, assign or sell any founder shares (except to permitted transferees), until the earlier
of: (A) one year after the completion of our initial business combination; and (B) subsequent to our initial business combination (x)
if the last reported sale price of our Class A ordinary shares equals or exceeds $12.00 per share (as adjusted for share sub-divisions,
share dividends, rights issuances, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day
period commencing at least 150 days after our initial business combination or (y) the date on which we complete a liquidation, merger,
share exchange, reorganization or other similar transaction that results in all of our public shareholders having the right to exchange
their ordinary shares for cash, securities or other property. Notwithstanding the foregoing, the letter agreement provides that, in connection
with an initial business combination, the initial holders may transfer, assign or sell their founder shares with our consent to any person
or entity that agrees in writing to be bound by the transfer restrictions set forth in the prior sentence, and any such transferee shall
be a permitted transferee under the letter agreement.
78
Private Placement
Simultaneously with the initial
public offering, our sponsor, CCM and KBW purchased in a private placement an aggregate of 760,000 placement units for an aggregate purchase
price of $7.6 million. There will be no redemption rights or liquidating distributions from the trust account with respect to the
founder shares, placement shares or placement warrants, which will expire worthless if we do not consummate a business combination within
the completion window.
The placement warrants underlying
the placement units are identical to the warrants sold as part of the units in the initial public offering except that: (1) they will
not be redeemable by us; (2) they (including the Class A ordinary shares issuable upon exercise of the warrants) may not, subject to certain
limited exceptions, be transferred, assigned or sold until 30 days after the completion of our initial business combination; (3) they
may be exercised by the holders on a cashless basis; and (4) they (including the ordinary shares issuable upon exercise of the warrants)
are entitled to registration rights. In addition, with respect to placement warrants held by CCM, KBW and/or their designees, such placement
warrants will be subject to the lock-up and registration rights limitations imposed by FINRA Rule 5110 and the placement warrants
will not be exercisable more than five years from the commencement of sales in the initial public offering in accordance with FINRA Rule
5110(g)(8).
Advance from related party
Starting in 2023, an affiliate
of the Company advanced us funds for working capital purposes. As of October 1, 2025, we repaid the outstanding balance amounting to $239,077
at the closing of the initial public offering.
Promissory Note — Related Party
On July 27, 2025, we issued
an unsecured promissory note to the sponsor (the “Promissory Note”), pursuant to which we could borrow up to an aggregate
principal amount of $500,000. The Promissory Note was non-interest bearing and payable on the earlier of (i) April 27, 2026 or (ii) the
consummation of the initial public offering. We repaid the outstanding balance of the Promissory Note on September 30, 2025. Borrowings
under the Promissory Note are no longer available.
Related Party Loans
In order to fund working capital
deficiencies or finance transaction costs in connection with a business combination, the sponsor or one of its affiliates may, but are
not obligated to, loan us additional funds to fund our additional working capital requirements and transaction costs (“Working Capital
Loans”). If we complete a business combination, we may repay the Working Capital Loans out of the proceeds of the trust account
released to us. Otherwise, the Working Capital Loans may be repaid only out of funds held outside the trust account. In the event that
a business combination does not close, we may use a portion of proceeds held outside the trust account to repay the Working Capital Loans
but no proceeds held in the trust account would be used to repay the Working Capital Loans. The Working Capital Loans would either be
repaid upon consummation of a Business Combination, without interest, or, at the lender’s discretion, up to $2,500,000 of such Working
Capital Loans may be convertible into units upon consummation of the business combination at a price of $10.00 per unit. The units would
be identical to the placement units. Prior to the completion of the initial business combination, the Company does not expect to seek
loans from parties other than the sponsor or an affiliate of the sponsor as the Company does not believe third parties will be willing
to loan such funds and provide a waiver against any and all rights to seek access to funds in the trust account. There were no working
capital loans outstanding as of December 31, 2025.
79
Registration Rights
Pursuant to a registration
rights agreement entered into on September 29, 2025, the holders of the founder shares, placement units (including securities contained
therein) and units (including securities contained therein) that may be issued upon conversion of loans made by our sponsor or one of
its affiliates, and their permitted transferees, have registration rights to require us to register a sale of any of our securities held
by them (in the case of the founder shares, only after conversion to our Class A ordinary shares). These holders are entitled to
make up to three demands, excluding short form registration demands, that we register such securities for sale under the Securities Act.
In addition, these holders have “piggy-back” registration rights to include such securities in other registration statements
filed by us and rights to require us to register for resale such securities pursuant to Rule 415 under the Securities Act. However,
the registration rights agreement provides that we will not be required to effect or permit any registration or cause any registration
statement to become effective until termination of the applicable lock-up period. Notwithstanding the foregoing, CCM, KBW and/or
their designees may not exercise their demand and “piggyback” registration rights after five and seven years from the commencement
of sales of the initial public offering and may not exercise their demand rights on more than one occasion. We will bear the expenses
incurred in connection with the filing of any such registration statements.
Administrative Services
Commencing on September 30,
2025, we pay an amount equal to $30,000 per month to our sponsor or its affiliate or designee for certain office space, utilities, and
shared personnel support services provided to us. Upon completion of a business combination or its liquidation, the Company will cease
paying these monthly fees.
Service Agreement
The Company has agreed, commencing
on September 29, 2025, through the earlier of the Company’s consummation of a business combination or its liquidation, to pay its
Chief Financial Officer, R. Maxwell Smeal, up to $12,500 per month.
Trust Account Indemnification
BTC Development Sponsor LLC
has agreed that, if the trust account is liquidated without the consummation of a business combination, it will indemnify us to the extent
any claims by a third party for services rendered or products sold to us, or any claims by a prospective target business with which we
have discussed entering into a transaction agreement, reduce the amount of funds in the trust account to below $10.00 per public share,
except for any claims by any third party who executed a waiver of any and all rights to seek access to the trust account, regardless of
whether such waiver is enforceable, and except for claims arising from our obligation to indemnify the underwriters of the initial public
offering pursuant to the underwriting agreement. We have not independently verified whether BTC Development Sponsor LLC has sufficient
funds to satisfy its indemnity obligations, we have not asked BTC Development Sponsor LLC to reserve for such obligations and it may not
be able to satisfy those obligations. We believe the likelihood of BTC Development Sponsor LLC having to indemnify the trust account is
limited because we endeavor to have all third parties that provide products or services to us and prospective target businesses execute
agreements with us waiving any right, title, interest or claim of any kind in or to monies held in the trust account.
Conflicts of Interest
Under Cayman Islands law,
directors and officers owe the following fiduciary duties:
●
duty to act in good faith in what the director or officer believes to be in the best interests of the company as a whole;
●
duty to exercise powers for the purposes for which those powers were conferred and not for a collateral purpose;
●
directors should not improperly fetter the exercise of future discretion;
●
duty to exercise powers fairly as between different sections of shareholders;
●
duty not to put themselves in a position in which there is a conflict between their duty to the company and their personal interests; and
●
duty to exercise independent judgment.
80
In addition to the above,
directors also owe a duty of care which is not fiduciary in nature. This duty has been defined as a requirement to act as a reasonably
diligent person having both the general knowledge, skill and experience that may reasonably be expected of a person carrying out the same
functions as are carried out by that director in relation to the company and the general knowledge skill and experience which that director
has.
As set out above, directors
have a duty not to put themselves in a position of conflict and this includes a duty not to engage in self-dealing, or to otherwise benefit
as a result of their position. However, in some instances what would otherwise be a breach of this duty can be forgiven and/or authorized
in advance by the shareholders provided that there is full disclosure by the directors. This can be done by way of permission granted
in the amended and restated memorandum and articles of association or alternatively by shareholder approval at general meetings.
In addition, members of our
management team and our board of directors directly or indirectly own founder shares and/or placement units, as set forth in “Principal
Shareholders,” and, accordingly, may have a conflict of interest in determining whether a particular target business is an appropriate
business with which to effectuate our initial business combination.
Each of our directors and
officers presently has, and in the future any of our directors and our officers may have additional, fiduciary or contractual obligations
to other entities pursuant to which such officer or director is or will be required to present acquisition opportunities to such entities.
Accordingly, subject to his or her fiduciary duties under Cayman Islands law, if any of our officers or directors becomes aware of an
acquisition opportunity which is suitable for an entity to which he or she has then current fiduciary or contractual obligations, he or
she will need to honor his or her fiduciary or contractual obligations to present such acquisition opportunity to such other entity, and
only present it to us if such entity rejects the opportunity. Our amended and restated memorandum and articles of association provide
that, to the fullest extent permitted by applicable law: (i) no individual serving as a director or an officer shall have any duty,
except and to the extent expressly assumed by contract, to refrain from engaging directly or indirectly in the same or similar business
activities or lines of business as us; and (ii) we renounce any interest or expectancy in, or in being offered an opportunity to participate
in, any potential transaction or matter which (a) may be a corporate opportunity for any director or officer, on the one hand, and us,
on the other or (b) the presentation of which would breach an existing legal obligation of a director or officer to any other entity.
As a result, the fiduciary duties or contractual obligations of our officers or directors could materially affect our ability to complete
our initial business combination. See “Risk Factors — Our officers and directors presently have, and any of them
in the future may have additional, fiduciary or contractual obligations to other entities, including other blank check companies, and,
accordingly, may have conflicts of interest in allocating their time and in determining to which entity a particular business opportunity
should be presented.” Accordingly, if any of our directors or officers become aware of a business combination opportunity which
is suitable for any of the entities to which he or she has then-current fiduciary or contractual obligations, he or she will honor
his or her fiduciary or contractual obligations to present such business combination opportunity to such entity, and only present it to
us if such entity rejects the opportunity, subject to his or her fiduciary duties under Cayman Islands law.
Additionally, if members of
our management team form other special purpose acquisition companies similar to ours or pursue other business or investment ventures during
the period in which we are seeking an initial business combination, the consideration paid, terms, conditions and timing relating to the
business combinations of such other special purpose acquisition companies or ventures, and the level of attention paid to by members of
our management team to them versus the level of attention paid to us may conflict in a way that is unfavorable to us. Consequently, our
directors’ and executive officers’ discretion in identifying and selecting a suitable target business may result in a conflict
of interest when determining whether the terms, conditions and timing of a particular business combination are appropriate and in our
shareholders’ best interest, which could negatively impact the timing for a business combination.
Potential investors should
also be aware of the following other potential conflicts of interest:
●
None of our officers or directors is required to commit his or her full time to our affairs and, accordingly, may have conflicts of interest in allocating his or her time among various business activities. We do not intend to have any full-time employees prior to the completion of our initial business combination. Each of our officers is engaged in several other business endeavors for which he may be entitled to substantial compensation, and our officers are not obligated to contribute any specific number of hours per week to our affairs.
81
●
Each of the holders of the founder shares and placement units has agreed that his, her or its founder shares and placement shares, as applicable, will be subject to transfer restrictions and that he, she or it will not sell or transfer such shares until the applicable forfeiture provisions no longer apply. Holders of founder shares and placement shares have agreed to waive their redemption rights with respect to their founder shares and placement shares, as applicable, (i) in connection with the consummation of a business combination, (ii) in connection with a shareholder vote to amend our amended and restated memorandum and articles of association to modify the substance or timing of our obligation to redeem 100% of our public shares if we do not complete our initial business combination within the completion window and (iii) if we fail to consummate a business combination within the completion window or if we liquidate prior to the expiration of the completion window. Our sponsor, officers and directors have also agreed to waive their redemption rights with respect to public shares in connection with the consummation of a business combination and in connection with a shareholder vote to amend our amended and restated memorandum and articles of association to modify the substance or timing of our obligation to redeem 100% of our public shares if we do not complete our initial business combination within the completion window. However, our sponsor, officers and directors will be entitled to redemption rights with respect to any public shares held by them if we fail to consummate a business combination or liquidate within the completion window. To the extent our holders of founder shares or placement shares transfer any of these securities to certain permitted transferees, such permitted transferees will agree, as a condition to such transfer, to waive these same redemption rights. If we do not complete our initial business combination within the completion window, the portion of the proceeds of the sale of the placement units placed into the trust account will be used to fund the redemption of our public shares. There will be no redemption rights or liquidating distributions with respect to our founder shares, placement shares or placement warrants, which will expire worthless if we do not consummate an initial business combination within the completion window. Except as described above, the founder shares, placement units and their underlying securities will not be transferable, assignable or salable.
●
Our officers and directors may have a conflict of interest with respect to evaluating a particular business combination if the retention or resignation of any such officers or directors was included by a target business as a condition to any agreement with respect to our initial business combination.
●
Prior to or in connection with the completion of our initial business combination, there may be payment by the company to any of our sponsor, officers or directors, or any of their respective affiliates, of consulting fees, finder’s fees, advisory fees or success fees for any services they render in order to effectuate the completion of our initial business combination, which, if made prior to the completion of our initial business combination, will be paid from funds held outside the trust account. See “Risk Factors — We may engage one or more affiliates of our sponsor, officers or directors or their respective affiliates to provide additional services to us, which may include acting as financial advisor in connection with an initial business combination. These financial incentives may cause them to have potential conflicts of interest in rendering any such additional services to us, including, for example, in connection with the sourcing and consummation of an initial business combination.”
●
our sponsor and members of our management team directly or indirectly own our securities, and accordingly, they may have a conflict of interest in determining whether a particular target business is an appropriate business with which to effectuate our initial business combination. Our sponsor has invested in us an aggregate of $5,150,000, comprised of the $25,000 purchase price for the founder shares (or approximately $0.003 per share) and the $5,125,000 purchase price for the placement units (or $10.00 per unit). The placement warrants underlying the placement units may be exercised cashlessly. Accordingly, our management team, which owns interests in our sponsor, may be more willing to pursue a business combination with a riskier or less-established target business than would be the case if our sponsor had paid the same per share price for the founder shares as our public shareholders paid for their public shares and if our sponsor were required to pay cash to exercise the placement warrants.
82
●
In the event our sponsor or members of our management team provide loans to us to finance transaction costs and/or incur expenses on our behalf in connection with an initial business combination, such persons may have a conflict of interest in determining whether a particular target business is an appropriate business with which to effectuate our initial business combination as such loans may not be repaid and/or such expenses may not be reimbursed unless we consummate such business combination.
●
We are not prohibited from pursuing an initial business combination with a company that is affiliated with our sponsor, officers or directors, or completing the business combination through a joint venture or other form of shared ownership with our sponsor, officers or directors; accordingly, such affiliated person(s) may have a conflict of interest in determining whether a particular target business is an appropriate business with which to effectuate our initial business combination as such affiliated person(s) would have interests different from our public shareholders and would likely not receive any financial benefit unless we consummated such business combination.
The conflicts described above
may not be resolved in our favor.
Accordingly, as a result of
multiple business affiliations, our officers and directors may have similar legal obligations relating to presenting business opportunities
meeting the above-listed criteria to multiple entities. Below is a table summarizing the entities to which our officers and directors
currently have fiduciary duties or contractual obligations:
Individual (1)
Entity
Affiliation
Betsy Z. Cohen
Cohen Circle Acquisition Corp. II
Cohen Circle FinTech Ventures, L.P.
Radiate Capital Fund, L.P.
Cohen Circle, LLC
President, CEO and Director
Managing Member
Managing Member
Co-Founder
Bracebridge H. Young, Jr.
Arabesque USA
Bracebridge Capital
NewMarket Investment Advisors
Cultivo Land PBC
Fold Holdings, Inc.
Social Finance, Inc.
Social Progress Imperative
Upwell Water
Executive Chairman
Vice Chairman
Board of Advisors
Director
Director
Chairman
Director
Board of Advisors
R. Maxwell Smeal
Cohen Circle, LLC
Cohen Circle Acquisition Corp. II
Art Technology Acquisition Corp.
Cohen Circle FinTech Ventures, L.P.
Radiate Capital Fund, L.P.
Chief Financial Officer
Chief Financial Officer
Chief Financial Officer
Chief Financial Officer
Chief Financial Officer
Jonathan Kirkwood
Ten31 LLC
Fold Holdings, Inc.
Battery Finance, Inc.
Start9 Labs, Inc.
Co-founder and Managing Partner Director
Director
Director
Andrew Hohns
Newmarket Capital
Fold Holdings, Inc.
Chief Executive Officer
Director
Grant Gilliam
Ten31 LLC
Zap Solutions Holdings, Inc
Co-founder and Managing Partner
Director
Hersh Kozlov
Duane Morris LLP
Bancorp, Inc.
Partner
Director
(1)
Each of the entities listed in this table may have priority and preference relative to our company with respect to the performance by each individual listed in this table of his or her obligations and the presentation by each such individual of business opportunities.
83
Our sponsor or any of its
affiliates may make additional investments in the company in connection with the initial business combination, although our sponsor and
its affiliates have no obligation or current intention to do so. If our sponsor or any of its affiliates elects to make additional investments,
such proposed investments could influence our sponsor’s motivation to complete an initial business combination. In addition, until
we consummate our initial business combination, affiliates of our sponsor, and our officers and directors may also participate in the
formation of, or become an officer or director of, another special purpose acquisition company.
In the event that we submit
our initial business combination to our public shareholders for a vote, our sponsor, officers and directors have agreed, pursuant to the
terms of a letter agreement entered into with us, to vote any founder shares and/or placement shares held by them (and their permitted
transferees will agree), and any public shares purchased during or after the initial public offering, in favor of our initial business
combination, aside from shares they may purchase in compliance with the requirements of Rule 14e-5 under the Exchange Act,
which would not be voted in favor of approving the business combination transaction.
Director Independence
The Nasdaq listing standards
require that a majority of our board of directors be independent. An “independent director” is defined generally as a person
who has no material relationship with the listed company (either directly or as a partner, shareholder or officer of an organization
that has a relationship with the company). Our board has determined that each of Betsy Z. Cohen, Jonathan Kirkwood, Andrew Hohns, Grant
Gilliam, and Hersh Kozlov are independent directors under applicable SEC and Nasdaq rules. Our independent directors will have regularly
scheduled meetings at which only independent directors are present.
Item 14. PRINCIPAL ACCOUNTANT FEES AND
SERVICES.
The firm of WithumSmith+Brown,
PC, or Withum, acted as our independent registered public accounting firm for the years ended December 31, 2025 and 2024. The following
is a summary of fees paid or to be paid to Withum for services rendered.
Audit Fees
Audit fees consist of fees
billed for professional services rendered for the audit of our year-end financial statements and services that are normally provided by
Withum in connection with regulatory filings. The aggregate fees billed by Withum for professional services rendered for the audit of
our annual financial statements, the initial public offering and other required filings with the SEC for the years ended December 31,
2025 and 2024 totaled $85,200 and $17,680, respectively.
Audit-Related Fees
Audit-related services consist
of fees billed for assurance and related services that are reasonably related to performance of the audit or review of our financial statements
and are not reported under “Audit Fees.” These services include attest services that are not required by statute or regulation
and consultations concerning financial accounting and reporting standards. We did not pay Withum for any audit-related services for the
years ended December 31, 2025 and 2024.
Tax Fees
For the years ended December
31, 2025 and 2024, Withum did not render services to us for tax compliance, tax advice and tax planning.
All Other Fees
We did not pay Withum for
other services for the years ended December 31, 2025 and 2024.
Audit Committee Pre-Approval Policies and Procedures
Our audit committee was formed
upon the consummation of the initial public offering. As a result, the audit committee did not pre-approve all of the foregoing services,
although any services rendered prior to the formation of our audit committee were approved by our board of directors. Since the formation
of our audit committee, and on a going-forward basis, the audit committee has and will pre-approve all auditing services and permitted
non-audit services to be performed for us by our auditors, including the fees and terms thereof (subject to the de minimis exceptions
for non-audit services described in the Exchange Act which are approved by the audit committee prior to the completion of the audit).
84
PART IV
Item 15. EXHIBITS AND FINANCIAL STATEMENT SCHEDULES.
(a) The
following documents are filed as part of this Annual Report:
(1)
Financial Statements:
Page
Report of Independent Registered Public Accounting Firm (PCAOB ID Number 100)
F-2
Financial Statements:
Balance Sheets as of December 31, 2025 and 2024
F-3
Statements of Operations for the Years Ended December 31, 2025 and 2024
F-4
Statements of Changes in Shareholders’ Deficit for the Years Ended December 31, 2025 and 2024
F-5
Statements of Cash Flows for the Years Ended December 31, 2025 and 2024
F-6
Notes to Financial Statements
F-7
(2) Financial
Statements Schedules:
None.
(3)
Exhibits
The following exhibits are
filed as part of, or incorporated by reference into, this Annual Report on Form 10-K. The SEC maintains an Internet site at www.sec.gov
that contains reports, proxy and information statements, and other information regarding issuers that file electronically with the SEC,
including the Company. Copies of the exhibits which are incorporated herein by reference can be obtained on the SEC website at www.sec.gov.
85
BTC DEVELOPMENT CORP.
INDEX TO FINANCIAL STATEMENTS
Report of Independent Registered Public Accounting Firm (PCAOB ID Number 100 ) F-2
Financial Statements:
Balance Sheets as of December 31, 2025 and 2024 F-3
Statements of Operations for the years ended December 31, 2025 and 2024 F-4
Statements of Changes in Shareholders’ Deficit for the years ended December 31, 2025 and 2024 F-5
Statements of Cash Flows for the years ended December 31, 2025 and 2024 F-6
Notes to Financial Statements F-7 to F-19
F- 1
REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
To the Shareholders and the Board of Directors of
BTC Development Corp.
Opinion on the Financial Statements
We have audited the accompanying balance sheets of BTC Development Corp. (the “Company”) as of December 31, 2025 and 2024, and the related statements of operations, changes in shareholders’ deficit, and cash flows for each of the two years in the period ended December 31, 2025, and the related notes (collectively referred to as the “financial statements”). In our opinion, the financial statements present fairly, in all material respects, the financial position of BTC Development Corp. as of December 31, 2025 and 2024, and the results of its operations and its cash flows for each of the two years in the period ended December 31, 2025, in conformity with the accounting principles generally accepted in the United States of America.
Basis for Opinion
These financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on the Company’s financial statements based on our audit. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (“PCAOB”) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.
We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audit, we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting. Accordingly, we express no such opinion.
Our audit included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audit also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audit provides a reasonable basis for our opinion.
/s/ WithumSmith+Brown, PC
We have served as the Company’s auditor since 2024.
New York , New York
March 24, 2026
PCAOB Number 100
F- 2
BTC DEVELOPMENT CORP.
BALANCE SHEETS
December 31,
2025
December 31,
2024
ASSETS
Current Assets:
Cash $ 1,985,699 $ —
Prepaid expenses 132,933 —
Prepaid insurance 87,500 —
Total Current Assets 2,206,132 —
Long-term prepaid insurance 65,625 —
Deferred offering costs — 329,930
Marketable securities held in Trust Account 255,012,555 —
Total Assets $ 257,284,312 $ 329,930
LIABILITIES, CLASS A ORDINARY SHARES SUBJECT TO POSSIBLE REDEMPTION, AND SHAREHOLDERS’ DEFICIT
Current Liabilities:
Accrued offering costs $ 75,000 $ 305,507
Accrued expenses 21,958 27,680
Advance from related party — 48,387
Total Current Liabilities 96,958 381,574
Deferred underwriting fee payable 10,780,000 —
Total Liabilities 10,876,958 381,574
Commitments and Contingencies (see Note 6)
Class A ordinary shares subject to possible redemption, 25,300,000 and no shares at a redemption value of $ 10.08 and none per share as of December 31, 2025 and 2024, respectively 255,012,555 —
Shareholders’ Deficit
Preference shares, $ 0.0001 par value; 1,000,000 shares authorized; none issued or outstanding — —
Class A ordinary shares, $ 0.0001 par value; 200,000,000 shares authorized; 760,000 shares and none issued or outstanding (excluding 25,300,000 shares subject to possible redemption) as of December 31, 2025 and 2024, respectively 76 —
Class B ordinary shares, $ 0.0001 par value; 20,000,000 shares authorized; 8,686,667 shares and 1 share issued and outstanding as of December 31, 2025 and 2024, respectively 869 —
Additional paid-in capital — —
Accumulated deficit ( 8,606,146 ) ( 51,644 )
Total Shareholders’ Deficit ( 8,605,201 ) ( 51,644 )
TOTAL LIABILITIES, CLASS A ORDINARY SHARES SUBJECT TO POSSIBLE REDEMPTION, AND SHAREHOLDERS’ DEFICIT $ 257,284,312 $ 329,930
The accompanying notes are an integral part of
the financial statements.
F- 3
BTC DEVELOPMENT CORP.
STATEMENTS OF OPERATIONS
For the Years Ended
December 31,
2025
2024
Formation, general and administrative costs $ 541,272 $ 33,592
Loss from Operations ( 541,272 ) ( 33,592 )
Other income:
Interest earned on marketable securities in Trust Account 2,412,555 —
Net income (loss) $ 1,871,283 $ ( 33,592 )
Weighted average shares Class A outstanding, basic and diluted 6,497,151 —
Basic and diluted net income (loss) per Class A ordinary share $ 0.13 $ —
Weighted average shares Class B outstanding, basic and diluted 7,860,914 1
Basic and diluted net income (loss) per Class B ordinary share $ 0.13 $ ( 33,592 )
The accompanying notes are an integral part of
the financial statements.
F- 4
BTC DEVELOPMENT CORP.
STATEMENTS OF CHANGES IN SHAREHOLDERS’
DEFICIT
Class A
Ordinary Shares
Class B
Ordinary Shares
Additional
Paid-in
Accumulated
Total
Shareholders’
Shares
Amount
Shares
Amount
Capital
Deficit
Deficit
Balance — January 1, 2024 — $ — — $ — $ — $ ( 18,052 ) $ ( 18,052 )
Net loss — — — — — ( 33,592 ) ( 33,592 )
Balance – December 31, 2024 — — — — — ( 51,644 ) ( 51,644 )
Issuance of Class B ordinary shares — — 8,686,667 869 24,131 — 25,000
Sale of 760,000 Private Placement Units 760,000 76 — — 7,599,924 — 7,600,000
Fair value of Public Warrants at issuance — — — — 1,518,000 — 1,518,000
Allocated value of transaction costs to Class A ordinary shares — — — — ( 121,075 ) — ( 121,075 )
Accretion for Class A ordinary shares to redemption amount — — — — ( 9,020,980 ) ( 10,425,785 ) ( 19,446,765 )
Net income — — — — — 1,871,283 1,871,283
Balance – December 31, 2025 760,000 $ 76 8,686,667 $ 869 $ — $ ( 8,606,146 ) $ ( 8,605,201 )
The accompanying notes are an integral
part of the financial statements.
F- 5
BTC DEVELOPMENT CORP.
STATEMENTS OF CASH FLOWS
For the Years Ended
December 31,
2025
2024
Cash Flows from Operating Activities:
Net income (loss) $ 1,871,283 $ ( 33,592 )
Adjustments to reconcile net income (loss) to net cash used in operating activities:
Payment of formation, general and administrative expenses through advances from related party 59,534 5,912
Payment of accrued expenses through advances from related party 27,680 —
Interest earned on Marketable securities held in Trust Account ( 2,412,555 ) —
Changes in operating assets and liabilities:
Prepaid expenses ( 132,933 ) —
Prepaid insurance ( 153,125 ) —
Accrued expenses ( 5,722 ) 27,680
Net cash used in operating activities ( 745,838 ) —
Cash Flows from Investing Activities:
Investment of cash into Trust Account ( 253,000,000 ) —
Cash withdrawn from Trust Account for working capital purposes 400,000
Net cash used in investing activities ( 252,600,000 ) —
Cash Flows from Financing Activities:
Proceeds from sale of Units, net of underwriting discounts paid 248,600,000 —
Proceeds from sale of Private Placement Units 7,600,000 —
Repayment of advances from related party ( 238,977 ) —
Proceeds due to Sponsor 5,200,000 —
Repayment of promissory note ( 5,200,000 ) —
Payment of offering costs ( 629,486 ) —
Net cash provided by financing activities 255,331,537 —
Net Change in Cash 1,985,699 —
Cash – Beginning of period — —
Cash – End of period $ 1,985,699 $ —
Supplemental disclosure of cash flow information:
Deferred offering costs included in accrued offering costs $ 75,000 $ 305,507
Deferred/accrued offering costs paid from advances from related party $ — $ 17,967
Advances from related party paid through the issuance of Class B ordinary shares $ — $ 6,456
Deferred underwriting fee payable $ 10,780,000 $ —
The accompanying notes are an integral
part of the financial statements.
F- 6
BTC DEVELOPMENT CORP.
NOTES TO FINANCIAL STATEMENTS
DECEMBER 31, 2025 AND 2024
NOTE 1 — DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS
BTC Development Corp. (the “Company”) was incorporated in the Cayman Islands on April 3, 2023 under the name ‘Cohen Circle Acquisition Corp. II.’ The name was changed to ‘Emerald Acquisition Corp. II’ on November 6, 2024 and then to ‘BTC Development Corp.’ on December 16, 2024. The Company was incorporated for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or other similar business combination involving one or more businesses or assets (the “Business Combination”). The Company is not limited to a particular industry or sector for purposes of consummating a Business Combination. The Company is an early stage and emerging growth company and, as such, the Company is subject to all of the risks associated with early stage and emerging growth companies.
As of December 31, 2025, the Company had not commenced any operations. All activity for the period from April 3, 2023 (inception) through December 31, 2025 relates to the Company’s formation, the initial public offering (“Initial Public Offering”), which is described below, and subsequent to the Initial Public Offering, identifying a target company for a Business Combination. The Company will not generate any operating revenues until after the completion of its initial Business Combination, at the earliest. The Company generates non-operating income in the form of interest income from the proceeds derived from the Initial Public Offering held in the Trust Account. The Company has selected December 31 as its fiscal year end.
The registration statement for the Company’s Initial Public Offering was declared effective on September 29, 2025. On October 1, 2025, the Company consummated the Initial Public Offering of 25,300,000 units (the “Units” and, with respect to the Class A ordinary shares included in the Units offered, the “Public Shares”) at $ 10.00 per Unit, which is discussed in Note 3, which includes the full exercise of the underwriters’ over-allotment option of 3,300,000 Units, generating gross proceeds of $ 253,000,000 .
Simultaneously with the closing of the Initial Public Offering, the Company consummated the sale of 760,000 units (each, a “Placement Unit” and collectively, the “Placement Units”) at a price of $ 10.00 per Placement Unit in a private placement to BTC Development Sponsor LLC, a Delaware limited liability company (together with BTC Development Advisors LLC, a Delaware limited liability company, the “sponsors”), and the underwriters, Cohen & Company Capital Markets, a division of Cohen & Company Securities, LLC (“CCM”) and Keefe, Bruyette & Woods, Inc. (“KBW”), generating gross proceeds of $ 7,600,000 . Of those 760,000 Placement Units, BTC Development Sponsor LLC purchased 512,500 Placement Units and CCM and KBW purchased an aggregate of 247,500 Placement Units.
Transaction costs amounted to $ 16,037,284 , consisting of $ 4,400,000 of cash underwriting fee, $ 10,780,000 of deferred underwriting fee, and $ 857,284 of other offering costs.
The Company’s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and the sale of Placement Units, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. There is no assurance that the Company will be able to complete a Business Combination successfully. The Company must complete one or more initial Business Combinations with one or more operating businesses or assets with a fair market value equal to at least 80 % of the net assets held in the Trust Account (as defined below) (excluding the deferred underwriting commissions and taxes payable on the interest earned on the Trust Account, if any). The Company will only complete a Business Combination if the post-transaction company owns or acquires 50 % or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target business sufficient for it not to be required to register as an investment company under the Investment Company Act of 1940, as amended (the “Investment Company Act”). Upon the closing of the Initial Public Offering on October 1, 2025, an amount of $ 253,000,000 ($ 10.00 per Unit) from the net proceeds of the sale of the Units are held in a trust account (“Trust Account”), located in the United States and invested only in (i) U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 under the Investment Company Act, which invest only in direct U.S. government treasury obligations, (ii) as uninvested cash, or (iii) an interest bearing bank demand deposit account or other accounts at a bank, until the earlier of (i) the completion of a Business Combination and (ii) the distribution of the funds held in the Trust Account as described below.
F- 7
The Company will provide the holders of the outstanding Public Shares (the “Public Shareholders”) with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a general meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek shareholder approval of a Business Combination or conduct a tender offer will be made by the Company. The Public Shareholders will be entitled to redeem their Public Shares for a pro rata portion of the amount then in the Trust Account (initially $ 10.00 per Public Share, plus any pro rata interest then in the Trust Account, net of permitted withdrawals). There will be no redemption rights upon the completion of a Business Combination with respect to the Company’s warrants. The Public Shares subject to redemption were recorded at a redemption value and classified as temporary equity upon the completion of the Initial Public Offering in accordance with the Accounting Standards Codification (“ASC”) Topic 480, “Distinguishing Liabilities from Equity.”
If the Company seeks shareholder approval, it will proceed with a Business Combination only if it obtains the approval of an ordinary resolution under Cayman Islands law, being the affirmative vote of the holders of a majority of the issued ordinary shares who, being present and entitled to vote at a general meeting of the Company, vote at a general meeting of the Company. If a shareholder vote is not required by applicable law or stock exchange listing requirements and the Company does not decide to hold a shareholder vote for business or other reasons, the Company will, pursuant to its Amended and Restated Memorandum and Articles of Association, conduct the redemptions pursuant to the tender offer rules of the U.S. Securities and Exchange Commission (the “SEC”) and file tender offer documents with the SEC prior to completing a Business Combination. If, however, shareholder approval of the transactions is required by applicable law or stock exchange listing requirements, or the Company decides to obtain shareholder approval for business or other reasons, the Company will offer to redeem shares in conjunction with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules. If the Company seeks shareholder approval in connection with a Business Combination, the sponsors have agreed to vote any Founder Shares (as defined in Note 5), Placement Shares (as defined in Note 4) and Public Shares held by them in favor of approving a Business Combination. Additionally, each Public Shareholder may elect to redeem their Public Shares, without voting, and if they do vote, irrespective of whether they vote for or against a proposed Business Combination or if they vote at all.
Notwithstanding the foregoing, if the Company seeks shareholder approval of a Business Combination and it does not conduct redemptions pursuant to the tender offer rules, the Company’s Amended and Restated Memorandum and Articles of Association provides that a Public Shareholder, together with any affiliate of such shareholder or any other person with whom such shareholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), will be restricted from redeeming its shares with respect to more than an aggregate of 15 % of the Public Shares without the prior consent of the Company. The Company may waive this restriction in its sole discretion.
The sponsors, officers and directors have agreed to waive (i) their redemption rights with respect to any Founder Shares and Placement Shares held by them in connection with the completion of the Company’s Business Combination and (ii) their redemption rights with respect to the Founder Shares and Placement Shares held by them in connection with a shareholder vote to approve an amendment to the Company’s Amended and Restated Memorandum and Articles of Association (A) to modify the substance or timing of the Company’s obligation to allow redemption in connection with a Business Combination or to redeem 100 % of the Public Shares if the Company does not complete a Business Combination within the Combination Period (as defined below) or (B) with respect to any other provision relating to shareholders’ rights or pre-initial Business Combination activity; and (iii) their rights to liquidating distributions from the Trust Account with respect to any Founder Shares and Placement Shares if the Company fails to complete its initial Business Combination within the Combination Period. However, the sponsors will be entitled to redemption rights with respect to Public Shares if the Company fails to consummate a Business Combination or liquidates within the Combination Period. CCM and KBW will have the same redemption rights as the Public Shareholders with respect to any Public Shares they acquire.
F- 8
The Company will have until 24 months from the closing of the Initial Public Offering (or 27 months from the closing of the Initial Public Offering if the Company has executed a definitive agreement for the initial Business Combination within 24 months from the closing of the Initial Public Offering but has not completed the initial Business Combination within such 24-month period) to complete a Business Combination (the “Combination Period”). If the Company has not completed a Business Combination within the Combination Period, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible, but not more than ten business days thereafter, redeem the Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest (net of permitted withdrawals and up to $ 100,000 of interest to pay dissolution expenses) divided by the number of then issued and outstanding Public Shares, which redemption will completely extinguish Public Shareholders’ rights as shareholders (including the right to receive further liquidating distributions, if any), and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the Company’s remaining shareholders and the Company’s board of directors, liquidate and dissolve, subject in each case to the Company’s obligations under Cayman Islands law to provide for claims of creditors and the requirements of other applicable law. There will be no redemption rights or liquidating distributions with respect to the Company’s warrants, which will expire worthless if the Company fails to complete a Business Combination within the Combination Period.
The underwriters have agreed to waive their rights to the deferred underwriting commission (see Note 6) held in the Trust Account in the event the Company does not complete a Business Combination within the Combination Period and, in such event, such amounts will be included with the other funds held in the Trust Account that will be available to fund the redemption of the Public Shares. In the event of such distribution, it is possible that the per share value of the assets remaining available for distribution will be less than $ 10.00 per share.
In order to protect the amounts held in the Trust Account, the sponsors have agreed to be liable to the Company if and to the extent any claims by a third party (except for the Company’s independent registered public accounting firm) for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amount of funds in the Trust Account to below the lesser of (i) $ 10.00 per Public Share or (ii) such lesser amount per Public Share held in the Trust Account as of the date of the liquidation of the Trust Account due to reductions in the value of the trust assets, in each case net of permitted withdrawals, except as to any claims by a third party who executed a waiver of any and all rights to seek access to the Trust Account, and except under the Company’s indemnity of the underwriters of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). Moreover, in the event that an executed waiver is deemed to be unenforceable against a third party, the sponsors will not be responsible to the extent of any liability for such third-party claims.
Liquidity and Capital Resources
As of December 31, 2025, the Company had $ 1,985,699 cash and working capital surplus of $ 2,109,174 .
In order to finance transaction costs in connection with a Business Combination, the sponsors or any affiliate of the sponsors may, but is not obligated to, loan the Company funds to fund the additional working capital requirements and transaction costs (“Working Capital Loans”). If the Company completes a Business Combination, the Company may repay the Working Capital Loans out of the proceeds of the Trust Account released to the Company. Otherwise, the Working Capital Loans may be repaid only out of funds held outside the Trust Account. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. The Working Capital Loans would either be repaid upon consummation of a Business Combination, without interest, or, at the lender’s discretion, up to $ 2,500,000 of such Working Capital Loans may be convertible at the option of the lender into units upon consummation of the Business Combination at a price of $ 10.00 per unit. The units would be identical to the Placement Units. As of December 31, 2025 and 2024, there were no amounts outstanding under the Working Capital Loans.
To fund working capital, the Company has permitted withdrawals available up to an annual limit of $ 400,000 . These permitted withdrawals are limited to only the interest available that has been earned in excess of the initial deposit at the Initial Public Offering. For the year ended December 31, 2025, the Company withdrew $ 400,000 in interest from the Trust Account for working capital purposes and has no further amounts available for permitted withdrawals until October 1, 2026, which is the 1-year anniversary of the Initial Public Offering.
In connection with the Company’s assessment of going concern considerations in accordance with Accounting Standards Codification (“ASC”) 205-40, “Presentation of Financial Statements – Going Concern,” the Company does not believe it will need to raise additional funds in order to meet the expenditures required for operating its business. However, if the estimate of the costs of identifying a target business, undertaking in-depth due diligence and negotiating a Business Combination are less than the actual amount necessary to do so, the Company may have insufficient funds available to operate its business prior to the initial Business Combination. Management has determined that the Company has sufficient funds to finance the working capital needs of the Company within one year from the date of issuance of the financial statements.
F- 9
NOTE 2 — SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Basis of Presentation
The accompanying financial statements are presented in U.S. dollars and have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and pursuant to the accounting and disclosure rules and regulations of the SEC.
Emerging Growth Company
The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved.
Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statement with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.
Use of Estimates
The preparation of the financial statements in conformity with U.S. GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements.
Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.
Cash and Cash Equivalents
The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had $ 1,985,699 and $ 0 in cash and no cash equivalents as of December 31, 2025 and 2024, respectively.
F- 10
Marketable Securities Held in Trust Account
As of December 31, 2025, substantially all the assets held in the Trust Account were held in money market funds, which are invested primarily in Treasury securities. As of December 31, 2024, there were no assets held in the Trust Account. All of the Company’s investments held in the Trust Account are presented on the accompanying balance sheets at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of investments held in Trust Account are included in interest earned on marketable securities held in Trust Account in the accompanying statements of operations. The estimated fair values of investments held in the Trust Account are determined using available market information.
To fund working capital, the Company has permitted withdrawals available up to an annual limit of $ 400,000 . These permitted withdrawals are limited to only the interest available that has been earned in excess of the initial deposit at the Initial Public Offering. For the year ended December 31, 2025, the Company withdrew $ 400,000 in interest from the Trust Account for working capital purposes and has no further amounts available for permitted withdrawals until October 1, 2026, which is the 1-year anniversary of the Initial Public Offering.
Offering Costs
The Company complies with the requirements of the ASC 340-10-S99 and SEC Staff Accounting Bulletin (“SAB”) Topic 5A — “Expenses of Offering”. Offering costs consist principally of professional and registration fees that are related to the Initial Public Offering. Financial Accounting Standards Board (“FASB”) ASC 470-20, “Debt with Conversion and Other Options”, addresses the allocation of proceeds from the issuance of convertible debt into its equity and debt components. The Company applies this guidance to allocate Initial Public Offering proceeds from the Units between Class A ordinary shares and warrants, using the residual method by allocating Initial Public Offering proceeds first to assigned value of the warrants and then to the Class A ordinary shares. Offering costs allocated to the Public Shares were charged to temporary equity, and offering costs allocated to the Public Warrants (as defined in Note 3) and Placement Units were charged to shareholders’ deficit as Public Warrants and Placement Warrants (as defined in Note 4), after management’s evaluation, were accounted for under equity treatment.
Fair Value of Financial Instruments
The fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC 820, “Fair Value Measurement,” approximates the carrying amounts represented in the balance sheets, primarily due to their short-term nature.
Class A Ordinary Shares Subject to Possible Redemption
The Public Shares contain a redemption feature which allows for the redemption of such Public Shares in connection with the Company’s liquidation, or if there is a shareholder vote or tender offer in connection with the Company’s initial Business Combination. In accordance with ASC 480-10-S99, the Company classifies Public Shares subject to possible redemption outside of permanent equity as the redemption provisions are not solely within the control of the Company. The Company recognizes changes in redemption value immediately as they occur and will adjust the carrying value of redeemable shares to equal the redemption value at the end of each reporting period. Immediately upon the closing of the Initial Public Offering, the Company recognized the accretion from initial book value to redemption value. The change in the carrying value of redeemable shares will result in charges against additional paid-in capital (to the extent available) and accumulated deficit. Accordingly, as of December 31, 2025, Class A ordinary shares subject to possible redemption are presented at redemption value as temporary equity, outside of the shareholders’ deficit section of the Company’s balance sheets.
To fund working capital, the Company has permitted withdrawals available up to an annual limit of $ 400,000 . These permitted withdrawals are limited to only the interest available that has been earned in excess of the initial deposit at the Initial Public Offering. For the year ended December 31, 2025, the Company withdrew $ 400,000 in interest from the Trust Account for working capital purposes and has no further amounts available for permitted withdrawals until October 1, 2026, which is the 1-year anniversary of the Initial Public Offering.
F- 11
As of December 31, 2025, the Class A ordinary shares subject to possible redemption reflected in the balance sheets are reconciled in the following table:
Gross proceeds: $ 253,000,000
Less:
Proceeds allocated to Public Warrants ( 1,518,000 )
Public Shares issuance costs ( 15,916,209 )
Plus:
Remeasurement of carrying value to redemption value 19,446,764
Class A ordinary shares subject to possible redemption, December 31, 2025 $ 255,012,555
Income Taxes
The Company accounts for income taxes under ASC Topic 740, “Income Taxes,” which requires an asset and liability approach to financial accounting and reporting for income taxes. Deferred income tax assets and liabilities are computed for differences between the financial statements and tax bases of assets and liabilities that will result in future taxable or deductible amounts, based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized.
ASC Topic 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company’s management determined that the Cayman Islands is the Company’s major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. As of December 31, 2025 and 2024, there were no unrecognized tax benefits and no amounts accrued for interest and penalties. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position.
The Company is considered to be an exempted Cayman Islands company with no connection to any other taxable jurisdiction and is presently not subject to income taxes or income tax filing requirements in the Cayman Islands or the United States. As such, the Company’s tax provision was zero for the period presented.
Net Income (Loss) per Ordinary Share
The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share”. Net income (loss) per Ordinary Share is computed by dividing net income (loss) by the weighted average number of Ordinary Shares outstanding for the period. Accretion associated with the redeemable Class A ordinary shares is excluded from net income (loss) per ordinary share as the redemption value approximates fair value.
The calculation of diluted net income (loss) does not consider the effect of the Public Warrants and the Placement Warrants to purchase an aggregate of 6,515,000 Class A ordinary shares in the calculation of diluted income per share, because in the calculation of diluted income per share, their exercise is contingent upon future events. As a result, diluted net income (loss) per share is the same as basic net income (loss) per share for the years ended December 31, 2025 and 2024. All accretions associated with the redeemable Class A ordinary shares are excluded from earnings per share as the redemption value approximates fair value.
F- 12
The following table reflects the calculation of basic and diluted net income (loss) per ordinary share:
For the Year Ended
December 31, 2025 For the Year Ended
December 31, 2024
Class A Class B Class A Class B
Basic and diluted net income (loss) per ordinary share:
Numerator:
Allocation of net income (loss) $ 846,772 $ 1,024,511 $ — $ ( 33,592 )
Denominator:
Weighted-average shares outstanding 6,497,151 7,860,914 — 1
Basic and diluted net income (loss) per ordinary share $ 0.13 $ 0.13 $ — $ ( 33,592 )
Concentration of Credit Risk
Financial instruments that potentially subject the Company to concentration of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Deposit Insurance Corporation coverage limit of $ 250,000 . Any loss incurred or a lack of access to such funds could have a significant adverse impact on the Company’s financial condition, results of operations, and cash flows.
Warrant Instruments
The Company accounts for the Public and Placement Warrants issued in connection with the Initial Public Offering and the private placement in accordance with the guidance contained in FASB ASC Topic 815, “Derivatives and Hedging”, whereby under that provision, the warrants that do not meet the criteria for equity treatment must be recorded as liability. Accordingly, the Company evaluated and classified the warrant instruments under equity treatment at their assigned values.
Recent Accounting Standards
In November 2023, the FASB issued ASU 2023-07, “Segment Reporting” (Topic 280): Improvements to Reportable Segment Disclosures. The amendments in this ASU require disclosures, on an annual and interim basis, of significant segment expenses that are regularly provided to the chief operating decision maker (“CODM”), as well as the aggregate amount of other segment items included in the reported measure of segment profit or loss. The ASU requires that a public entity disclose the title and position of the CODM and an explanation of how the CODM uses the reported measure(s) of segment profit or loss in assessing segment performance and deciding how to allocate resources. Public entities will be required to provide all annual disclosures currently required by Topic 280 in interim periods, and entities with a single reportable segment are required to provide all the disclosures required by the amendments in this ASU and existing segment disclosures in Topic 280. This ASU is effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024, with early adoption permitted. The Company adopted ASU 2023-07 as required for the year ended December 31, 2024.
Management does not believe that any other recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company’s financial statement.
F- 13
NOTE 3 — INITIAL PUBLIC OFFERING
Pursuant to the Initial Public Offering on October 1, 2025, the Company sold 25,300,000 Units, which includes the full exercise of the underwriters’ overallotment option in the amount of 3,300,000 Units, at a price of $ 10.00 per Unit for a total of $ 253,000,000 . Each Unit consists of one Class A ordinary share and one-fourth of one redeemable warrant (“Public Warrant”). Each whole Public Warrant entitles the holder to purchase one Class A ordinary share at a price of $ 11.50 per share, subject to adjustment (see Note 7).
NOTE 4 — PRIVATE PLACEMENT
Simultaneously with the closing of the Initial Public Offering, the sponsors, CCM and KBW purchased an aggregate of 760,000 Placement Units (at a price of $ 10.00 per Placement Unit, for an aggregate purchase price of $ 7,600,000 , of which 512,500 Placement Units were purchased by one of the sponsors, BTC Development Sponsor LLC, and an aggregate of 247,500 Placement Units were purchased by CCM and KBW. Each Placement Unit consists of one Class A ordinary share (“Placement Share” or, collectively, “Placement Shares”) and one-fourth of one warrant (each, a “Placement Warrant”). Each whole Placement Warrant is exercisable to purchase one Class A ordinary share at a price of $ 11.50 per share, subject to adjustment (see Note 7). If the Company does not complete a Business Combination within the Combination Period, the proceeds from the sale of the Placement Units will be used to fund the redemption of the Public Shares (subject to the requirements of applicable law), and the Placement Units and all underlying securities will expire worthless.
NOTE 5 — RELATED PARTY TRANSACTIONS
Founder Shares
On April 4, 2023, BTC Development Sponsor LLC (f/k/a Cohen Circle Sponsor II, LLC) paid $ 25,000 to cover certain offering costs of the Company and became a holder of 1 Class B ordinary share (the “Founder Shares”). On August 11, 2025, the Company cancelled the one Founder Share and issued 8,686,667 Founder Shares to BTC Development Sponsor LLC. On September 5, 2025, BTC Development Sponsor LLC transferred 4,095,833 Founder Shares to BTC Development Advisors LLC. The Founder Shares included an aggregate of up to 1,100,000 shares subject to forfeiture to the extent that the underwriters’ over-allotment option is not exercised in full or in part, so that the number of Founder Shares will equal 25 % of the Company’s issued and outstanding shares after the Initial Public Offering and the private placement. On October 1, 2025, the underwriters exercised their over-allotment option in full as part of the closing of the Initial Public Offering. As such, the 1,100,000 Founder Shares are no longer subject to forfeiture.
The sponsors have agreed, subject to limited exceptions, not to transfer, assign or sell any of the Founder Shares until the earlier to occur of: (A) one year after the completion of the Business Combination; and (B) subsequent to the Business Combination (x) if the last reported sale price of the Class A ordinary shares equals or exceeds $ 12.00 per share (as adjusted for share sub-divisions, share dividends, rights issuances, reorganizations, recapitalizations and the like) for any 20 trading days within any 30 -trading day period commencing at least 150 days after the Business Combination or (y) the date on which the Company completes a liquidation, merger, share exchange, reorganization or other similar transaction that results in all of the Company’s public shareholders having the right to exchange their ordinary shares for cash, securities or other property. Any permitted transferees would be subject to the same restrictions and other agreements of the initial shareholders with respect to any Founder Shares.
Administrative Support Agreement
The Company has agreed, commencing on September 30, 2025, through the earlier of the Company’s consummation of a Business Combination or its liquidation, to pay an affiliate or designee of the sponsors a total of $ 30,000 per month for office space, utilities and shared personnel support services. For the year ended December 31, 2025, the Company incurred and paid $ 90,000 in fees for these services of which such amount is recorded within general and administrative fees on the accompanying statements of operations. For the year ended December 31, 2024, no expenses were incurred for these services.
F- 14
Advance from Related Party
Starting in 2023 an affiliate of the Company advanced the Company funds for working capital purposes. This amount is reflected on the balance sheets as advance from related party. On October 1, 2025, the Company repaid the outstanding balance amounting to $ 239,077 at the closing of the Initial Public Offering and are no longer available. As of December 31, 2025 and 2024, the Company had outstanding balance of $ 0 and $ 48,387 under the advance from related party, respectively.
Promissory Note
On July 27, 2025, the Sponsor agreed to loan the Company an aggregate of up to $ 500,000 to cover expenses related to the Initial Public Offering pursuant to a promissory note (the “Note”). This loan is non-interest bearing and payable on the earlier of April 27, 2026 or the completion of the Initial Public Offering. On September 30, 2025, the Company repaid the total outstanding balance of the Promissory Note and borrowings under the Note are no longer available.
Service Agreement
The Company has agreed, commencing on the effective date of the Initial Public Offering through the earlier of the Company’s consummation of a Business Combination or its liquidation, to pay its Chief Financial Officer, R. Maxwell Smeal, up to $ 12,500 per month. For the year ended December 31, 2025, the Company incurred $ 37,500 in fees for these services of which such amount is recorded within general and administrative fees on the accompanying statements of operations. Of these fees, $ 19,667 were paid and $ 17,833 are included in the accrued expenses line in the accompanying balance sheets. For the year ended December 31, 2024, no expenses were incurred for these services.
Related Party Loans
In addition, in order to finance transaction costs in connection with a Business Combination, the sponsors or any affiliate of the sponsors may, but is not obligated to, loan the Company funds to fund the additional working capital requirements and transaction costs (“Working Capital Loans”). If the Company completes a Business Combination, the Company may repay the Working Capital Loans out of the proceeds of the Trust Account released to the Company. Otherwise, the Working Capital Loans may be repaid only out of funds held outside the Trust Account. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. The Working Capital Loans would either be repaid upon consummation of a Business Combination, without interest, or, at the lender’s discretion, up to $ 2,500,000 of such Working Capital Loans may be convertible into units upon consummation of the Business Combination at a price of $ 10.00 per unit. The units would be identical to the Placement Units. As of December 31, 2025 and 2024, there were no amounts outstanding under the Working Capital Loans.
NOTE 6 — COMMITMENTS AND CONTINGENCIES
Risks and Uncertainties
The United States and global markets are experiencing volatility and disruption following the geopolitical instability resulting from the ongoing Russia-Ukraine conflict and the Israel-Hamas conflict. In response to the ongoing Russia-Ukraine conflict, the North Atlantic Treaty Organization (“NATO”) deployed additional military forces to eastern Europe, and the United States, the United Kingdom, the European Union and other countries have announced various sanctions and restrictive actions against Russia, Belarus and related individuals and entities, including the removal of certain financial institutions from the Society for Worldwide Interbank Financial Telecommunication payment system. Certain countries, including the United States, have also provided and may continue to provide military aid or other assistance to Ukraine and to Israel, increasing geopolitical tensions among a number of nations. The invasion of Ukraine by Russia and the Israel-Hamas conflict and the resulting measures that have been taken, and could be taken in the future, by NATO, the United States, the United Kingdom, the European Union, Israel and its neighboring states and other countries have created global security concerns that could have a lasting impact on regional and global economies. Although the length and impact of the ongoing conflicts are highly unpredictable, they could lead to market disruptions, including significant volatility in commodity prices, credit and capital markets, as well as supply chain interruptions and increased cyber-attacks against U.S. companies. Additionally, any resulting sanctions could adversely affect the global economy and financial markets and lead to instability and lack of liquidity in capital markets.
Any of the above mentioned factors, or any other negative impact on the global economy, capital markets or other geopolitical conditions resulting from the Russian invasion of Ukraine, the Israel-Hamas conflict and subsequent sanctions or related actions, could adversely affect the Company’s search for an initial Business Combination and any target business with which the Company may ultimately consummate an initial Business Combination.
F- 15
Registration Rights
The holders of the Founder Shares, Placement Units (including securities contained therein) and units (including securities contained therein) that may be issued upon conversion of Working Capital Loans, and any Class A ordinary shares issuable upon the exercise of the Placement Warrants and any Class A ordinary shares and warrants (and underlying Class A ordinary shares) that may be issued upon conversion of the units issued as part of the Working Capital Loans and Class A ordinary shares issuable upon conversion of the Founder Shares, are entitled to registration rights pursuant to a registration rights agreement signed on the effective date of the Initial Public Offering, requiring the Company to register such securities for resale (in the case of the Founder Shares, only after conversion to the Class A ordinary shares). These holders will be entitled to make up to three demands, excluding short form registration demands, that the Company register such securities for sale under the Securities Act. In addition, these holders will have “piggyback” registration rights to include such securities in other registration statements filed by the Company and rights to require the Company to register for resale such securities pursuant to Rule 415 under the Securities Act. However, the registration rights agreement provides that the Company will not permit any registration statement filed under the Securities Act to become effective until termination of the applicable lock-up period. The registration rights agreement does not contain liquidated damages or other cash settlement provisions resulting from delays in registering the Company’s securities. Notwithstanding the foregoing, CCM and KBW and/or their designees may not exercise their demand and “piggyback” registration rights after five and seven years after the effective date of the Initial Public Offering, and may not exercise its demand rights on more than one occasion. The Company will bear the expenses incurred in connection with the filing of any such registration statements.
Underwriting Agreement
The Company granted the underwriters, Cohen & Company Capital Markets, an affiliate of the sponsors, and Keefe, Bruyette & Woods, Inc., a 45-day option from the date of the Initial Public Offering to purchase up to 3,300,000 additional Units to cover over-allotments, if any, at the Initial Public Offering price, less the underwriting discounts and commissions. On October 1, 2025, simultaneously with the closing of the Initial Public Offering, the underwriters elected to fully exercise the over-allotment option to purchase the additional 3,300,000 Units at a price of $ 10.00 per Unit.
The underwriters were entitled to a cash underwriting discount of $ 0.20 per Unit or $ 4,400,000 in the aggregate, which was paid at the closing of the Initial Public Offering. In addition, (i) $ 0.40 per unit sold in the base offering, or $ 8,800,000 in the aggregate, and (ii) $ 0.60 per unit sold pursuant to the underwriters’ over-allotment option, or $ 1,980,000 in the aggregate, is payable to the underwriters for deferred underwriting commissions held in the Trust Account. The deferred commissions will be released to CCM and KBW for their own accounts concurrently with completion of an initial Business Combination.
NOTE 7 — SHAREHOLDERS’ DEFICIT
Preference Shares — The Company is authorized to issue 1,000,000 preference shares with a par value of $ 0.0001 per share with such designations, voting and other rights and preferences as may be determined from time to time by the Company’s board of directors. At December 31, 2025 and 2024, there were no preference shares issued or outstanding.
Class A Ordinary Shares — The Company is authorized to issue 200,000,000 Class A ordinary shares with a par value of $ 0.0001 per share. Holders of ordinary shares are entitled to one vote for each share. At December 31, 2025 and 2024, there were 760,000 and no Class A ordinary shares issued and outstanding, excluding 25,300,000 and 0 shares subject to possible redemption, respectively.
Class B Ordinary Shares — The Company is authorized to issue 20,000,000 Class B ordinary shares with a par value of $ 0.0001 per share. Holders of ordinary shares are entitled to one vote for each share. As of December 31, 2025 and 2024, there were 8,686,667 and 1 Class B ordinary shares issued and outstanding, respectively.
Warrants — As of December 31, 2025, there were 6,325,000 Public Warrants and 190,000 Placement Warrants outstanding. As of December 31, 2024, there were no Public Warrants and Placement Warrants outstanding. Public Warrants may only be exercised for a whole number of shares. No fractional warrants will be issued upon separation of the Units and only whole warrants will trade. The Public Warrants will become exercisable on the later of 30 days after the completion of a Business Combination and 12 months from the closing of the Initial Public Offering. The Public Warrants will expire five years after the completion of a Business Combination or earlier upon redemption or liquidation.
F- 16
The Company will not be obligated to deliver any Class A ordinary shares pursuant to the exercise of a warrant and will have no obligation to settle such warrant exercise unless a registration statement under the Securities Act with respect to the Class A ordinary shares underlying the warrants is then effective and a prospectus relating thereto is current, subject to the Company satisfying its obligations with respect to registration. No warrant will be exercisable and the Company will not be obligated to issue any Class A ordinary shares upon exercise of a warrant unless the issuance of the shares upon such exercise is registered or qualified under the securities laws of the state of the exercising holder, or an exemption is available.
The Company has agreed that as soon as practicable, but in no event later than 20 business days after the closing of a Business Combination, the Company will use its best efforts to file, and within 60 business days following a Business Combination to have declared effective, a registration statement covering the Class A ordinary shares issuable upon exercise of the warrants. The Company will use its best efforts to cause the same to become effective and to maintain the effectiveness of such registration statement, and a current prospectus relating thereto, until the expiration of the warrants in accordance with the provisions of the warrant agreement. Notwithstanding the foregoing, if a registration statement covering the Class A ordinary shares issuable upon exercise of the warrants is not effective within a specified period following the consummation of a Business Combination, warrant holders may, until such time as there is an effective registration statement and during any period when the Company shall have failed to maintain an effective registration statement, exercise warrants on a cashless basis pursuant to the exemption provided by Section 3(a)(9) of the Securities Act, provided that such exemption is available. If that exemption, or another exemption, is not available, holders will not be able to exercise their warrants on a cashless basis.
Redemption of warrants when the price per Class A ordinary share equals or exceeds $ 18.00 . Once the Warrants become exercisable, the Company may redeem the Warrants:
● in whole and not in part;
● at a price of $ 0.01 per warrant;
● upon not less than 30 days’ prior written notice of redemption to each warrant holder and
● if, and only if, the closing price of the Company’s Class A ordinary shares equals or exceeds $ 18.00 per share (as adjusted for share sub-divisions, share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within a 30 -trading day period ending on the third trading day prior to the date on which the notice of redemption is given to the warrant holders.
If and when the warrants become redeemable by the Company, the Company may exercise its redemption right even if it is unable to register or qualify the underlying securities for sale under all applicable state securities laws.
In addition, if (x) the Company issues additional Class A ordinary shares or equity-linked securities for capital raising purposes in connection with the closing of a Business Combination at an issue price or effective issue price of less than $ 9.20 per ordinary share (with such issue price or effective issue price to be determined in good faith by the Company’s board of directors, and, in the case of any such issuance to the sponsors or their respective affiliates, without taking into account any Founder Shares held by the sponsors or their respective affiliates, as applicable, prior to such issuance) (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60 % of the total equity proceeds, and interest thereon, available for the funding of a Business Combination on the date of the completion of a Business Combination (net of redemptions), and (z) the volume-weighted average trading price of the Class A ordinary shares during the 20 trading day period starting on the trading day prior to the day on which the Company completes a Business Combination (such price, the “Market Value”) is below $ 9.20 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115 % of the higher of the Market Value and the Newly Issued Price, and the $ 18.00 per share redemption trigger price will be adjusted (to the nearest cent) to be equal to 180 % of the higher of the Market Value and the Newly Issued Price.
The Placement Warrants are identical to the Public Warrants underlying the Units sold in the Initial Public Offering, except that the Placement Warrants and the Class A ordinary shares issuable upon the exercise of the Placement Warrants will not be transferable, assignable or salable until 30 days after the completion of a Business Combination, subject to certain limited exceptions. Additionally, the Placement Warrants will be exercisable on a cashless basis and be non-redeemable.
F- 17
NOTE 8 — FAIR VALUE MEASUREMENTS
Fair Value Measurements
Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. U.S. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include:
● Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets;
● Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and
● Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.
The fair value of the Public Warrants at issuance was $ 1,518,000 or $ 0.24 per public warrant. The fair value of Public Warrants was determined using binomial or lattice model. The Public Warrants have been classified within shareholders’ deficit and will not require remeasurement after issuance. The following table presents the quantitative information regarding market assumptions used in the level 3 valuation of the Public Warrants:
October 1,
2025
Volatility 15.0 %
Risk free rate 3.7 %
Dividend yield 0.0 %
Share price $ 10.16
Exercise price $ 11.50
Term 5.5
Probability of Business Combination 15.0 %
At December 31, 2025, assets held in the Trust Account were comprised of $ 255,012,555 in money market funds which are invested primarily in U.S. Treasury Securities. To fund working capital, the Company has permitted withdrawals available up to an annual limit of $ 400,000 . These permitted withdrawals are limited to only the interest available that has been earned in excess of the initial deposit at the Initial Public Offering. For the year ended December 31, 2025, the Company withdrew $ 400,000 in interest from the Trust Account for working capital purposes and has no further amounts available for permitted withdrawals until October 1, 2026, which is the 1-year anniversary of the Initial Public Offering.
At December 31, 2024, there were no assets held in the Trust Account.
The following table presents information about the Company’s assets that are measured at fair value as of December 31, 2025 and 2024, and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value:
Level December 31,
2025 December 31,
2024
Assets:
Marketable securities held in Trust Account 1 $ 255,012,555 $ —
F- 18
NOTE 9 — SEGMENT INFORMATION
ASC Topic 280, “Segment Reporting,” establishes standards for companies to report in their financial statements information about operating segments, products, services, geographic areas, and major customers. Operating segments are defined as components of an enterprise for which separate financial information is available that is regularly evaluated by the Company’s CODM, or group, in deciding how to allocate resources and assess performance.
The Company’s CODM has been identified as the Chief Financial Officer , who reviews the assets, operating results, and financial metrics for the Company as a whole to make decisions about allocating resources and assessing financial performance. Accordingly, management has determined that the Company only has one reportable segment.
The CODM assesses performance for the single segment and decides how to allocate resources. The measure of segment assets is reported on the balance sheets as total assets. When evaluating the Company’s performance and making key decisions regarding resource allocation, the CODM reviews several key metrics included in total assets, which include the following:
December 31,
2025 December 31,
2024
Cash $ 1,985,699 $ —
Marketable securities held in Trust Account $ 255,012,555 $ —
For the
Year Ended
December 31,
2025 For the
Year Ended
December 31,
2024
Formation, general and administrative costs $ 541,272 $ 33,592
Interest earned on marketable securities held in Trust Account $ 2,412,555 $ —
The CODM reviews interest earned on marketable securities held in the Trust Account to measure and monitor shareholder value and determine the most effective strategy of investment with the Trust Account funds while maintaining compliance with the Trust Agreement.
Formation, general and administrative costs are reviewed and monitored by the CODM to manage and forecast cash to ensure enough capital is available to complete a Business Combination or similar transaction within the Combination Period. The CODM also reviews formation, general and administrative costs to manage, maintain and enforce all contractual agreements to ensure costs are aligned with all agreements and budget. Formation, general and administrative costs, as reported on the accompanying statements of operations, are the significant segment expenses provided to the CODM on a regular basis.
All other segment items included in net income or loss are reported on the accompanying statements of operations and described within their respective disclosures.
NOTE 10 — SUBSEQUENT EVENTS
The Company evaluated subsequent events and transactions that occurred after the balance sheet date up to the date that the financial statements were issued. Based upon this review, the Company did not identify any subsequent events that would have required adjustment or disclosure in the financial statements.
F- 19
Exhibit
No.
Description
1.1
Underwriting Agreement, dated September 29, 2025, between the Company, Cohen & Company Capital Markets, a division of Cohen & Company Securities, LLC, and Keefe, Bruyette & Woods, Inc. (1)
3.1
Amended and Restated Memorandum and Articles of Association(2)
3.2
Amended and Restated Memorandum and Articles of Association, filed with the Cayman Islands General Registry on September 29, 2025(1)
4.1
Specimen Unit Certificate (2)
4.2
Specimen Class A Ordinary Share Certificate (2)
4.3
Specimen Warrant Certificate (included on Exhibit 4.4)
4.4
Warrant Agreement, dated September 29, 2025, by and between Continental Stock Transfer & Trust Company and the Company (1)
4.5*
BTC Development Corp. Description of Securities
10.1
Letter Agreement, dated September 29, 2025, by and among the Company and certain security holders, officers and directors of the Company (1)
10.2
Investment Management Trust Agreement, dated September 29, 2025, by and between the Company and Continental Stock Transfer & Trust Company (1)
10.3
Registration Rights Agreement, dated September 29, 2025, by and among the Company and certain security holders of the Company (1)
10.4
Placement
Unit Subscription Agreement, dated September 29, 2025 by and between the Company and BTC Development Sponsor LLC (1)
10.5
Placement Unit Subscription Agreement, dated September 29, 2025 by and between the Company and Cohen & Company Capital Markets, a division of Cohen & Company Securities, LLC (1)
10.6
Placement Unit Subscription Agreement, dated S eptember 29 , 2025 by and between the Company and Keefe, Bruyette & Woods, Inc. (1)
10.7
Administrative Services Agreement, dated September 29, 2025, by and between the Company and BTC Development Sponsor LLC (1)
10.8
Form of Indemnity Agreement (1)
10.9
Securities Subscription Agreement, dated August 11, 2025, between the Company and BTC Development Sponsor LLC (2)
14.1
Code of Ethics(2)
19*
Insider Trading Policies and Procedures
21.1*
Subsidiaries of the Registrant
31.1*
Certification of the Chief Executive Officer required by Rule 13a-14(a) or Rule 15d-14(a)
31.2*
Certification of the Chief Financial Officer required by Rule 13a-14(a) or Rule 15d-14(a)
32.1*
Certification of the Chief Executive Officer required by Rule 13a-14(b) or Rule 15d-14(b) and 18 U.S.C. 1350
32.2*
Certification of the Chief Financial Officer required by Rule 13a-14(b) or Rule 15d-14(b) and 18 U.S.C. 1350
97*
Policy Related to Recovery of Erroneously Awarded Compensation
101.INS*
Inline XBRL Instance Document
101.CAL*
Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.SCH*
Inline XBRL Taxonomy Extension Schema Document
101.DEF*
Inline XBRL Taxonomy Extension Definition Linkbase Document
101.LAB*
Inline XBRL Taxonomy Extension Labels Linkbase Document
101.PRE*
Inline XBRL Taxonomy Extension Presentation Linkbase Document
104
Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).
*
Filed herewith
(1)
Previously filed as an exhibit to our Current Report on Form 8-K filed on October 3, 2025
(2)
Previously filed as an exhibit to our Registration Statement on Form S-1, as amended (File No. 333-289705)
Item 16. FORM 10-K SUMMARY.
Not applicable.
86
SIGNATURES
In accordance with the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto
duly authorized.
BTC DEVELOPMENT CORP.
Dated: March 24, 2026
/s/ Bracebridge H. Young, Jr.
Bracebridge H. Young, Jr.
President and Chief Executive Officer
(Principal Executive Officer)
Pursuant to the requirements
of the Securities Exchange Act of 1934, this Report has been signed below by the following persons on behalf of the registrant and in
the capacities and on the dates indicated.
Name
Position
Date
/s/ Bracebridge H. Young, Jr.
President, Chief Executive Officer and Director
March 24, 2026
Bracebridge H. Young, Jr.
(Principal Executive Officer)
/s/ R. Maxwell Smeal
Chief Financial Officer
March 24, 2026
R. Maxwell Smeal
( Principal Financial and Accounting Officer )
/s/ Betsy Z. Cohen
Chairman of the Board
March 24, 2026
Betsy Z. Cohen
/s/ Jonathan Kirkwood
Vice Chairman of the Board
March 24, 2026
Jonathan Kirkwood
/s/ Andrew Hohns
Director
March 24, 2026
Andrew Hohns
/s/ Grant Gilliam
Director
March 24, 2026
Grant Gilliam
/s/ Hersh Kozlov
Director
March 24, 2026
Hersh Kozlov
87